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 Cardiac arrest (CA) occurs in over 347,000 adult Americans annually and is a 
leading cause of morbidity and mortality. While targeted temperature management 
(TTM), a neuroprotective treatment, is often implemented following resuscitation, CA 
typically results in an ischemic brain injury that is detrimental to functional outcome. 
Prognosis shortly following CA is crucial as it may guide subsequent treatment. Although 
multiple prognostic tools exist, many have not been verified under TTM or have 
limitations in early prognostication. Thus, a reliable tool that predicts functional outcome 
during the early recovery period after CA is required. For this project, it was necessary to 
first review current literature detailing the existing prognostic tools and their limitations.  
 Many of the prognostic tools that have been employed have limitations including 
subjective results interpretation and the confounding effects of the sedatives required for 
TTM. However, somatosensory evoked potentials (SSEP) and electroencephalogram 
(EEG) have potential to track recovery. The bilateral absence of the human N20 SSEP 
peak is currently the most reliable predictor of poor outcome, however, the signal 
interpretation is subjective and limited by the dichotomous categorization. Thus, the next 
step in this work included quantitative analyses of SSEP signals to identify objective 
prognostic markers.   
 First, the peak amplitude and latency of SSEP signals were calculated. The 
amplitude of N10 peaks and latency of N7 and N10 peaks in rats were measured 
objectively and were distinct among temperature and outcome groups. A more complex 
 iii
and novel calculation of the SSEP phase space area (qSSEP-PSA), which considers 
multiple SSEP characteristics, was then performed. Animals treated with hypothermia 
tended to have higher qSSEP-PSA values and better qSSEP-PSA recovery over the early 
recovery period. These analyses demonstrate that quantitative SSEPs can track brain 
recovery shortly after resuscitation.  
EEG is a common brain-monitoring tool. The information quantity (IQ), a 
quantitative measure of the EEG information content, was calculated in post-CA rats that 
underwent laser speckle contrast imaging (LSCI), which measures relative cerebral blood 
flow (rCBF). IQ was significantly and negatively correlated with rCBF during the early 
recovery, suggesting that electrical activity recovery can be maintained by lower rCBF 
shortly after CA.  
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CHAPTER 1: TRACKING EARLY BRAIN RECOVERY 
FOLLOWING CARDIAC ARREST WITH TARGETED 
TEMPERATURE MANAGEMENT 
1.1   Cardiac Arrest 
1.1.1   Prevalence and Impact of Cardiac Arrest 
An estimated 320,200 adults suffer from out-of-hospital cardiac arrest (CA) in the United 
States annually [1]. Survival to discharge rate among adults is a mere 10.6% while the 
rate of good functional outcome is only 8.3% [1]. While the treatments to improve 
outcome after CA are progressing, it remains one of the leading causes of unexpected 
death and many patients remain comatose following resuscitation, die before discharge or 
have poor functional outcome after awakening. CA is one of the primary causes of 
morbidity and mortality [2]. In addition to the physical impacts of CA, there are 
significant economic impacts resulting in societal burdens, defined by the productive 
years of life lost, equal to or greater than other leading causes of death in the US [3]. 
Thus, the major societal impact of CA underlies the importance of improving 
prognostication and treatment of post-CA patients to increase survival rates and 
neurologic recovery.   
  
2 
1.1.2   Cerebral Ischemia  
During CA, cerebral ischemia occurs such that the brain fails to receive enough blood to 
maintain metabolic processes, causing a hypoxic-ischemic cerebral injury. While the 
injury due to the cardiac event may last for hours or days, it is believed that the primary 
damage occurs during the ischemic episode and reperfusion [4]. It is well documented 
and accepted that the neurotoxicity caused by cerebral ischemia is, at least in part, due to 
increases in extracellular glutamate during cerebral ischemia [5] and reperfusion [6, 7], 
leading to excitotoxicity [8-10]. The hyperexcitability seen in ischemic injury is likely a 
combination of both increased excitation and decrease in inhibition, as it is suggested that 
impairment to GABAergic neurons, associated with inhibitory functions, may play a role 
in overexcitation [11]. However, the neurotoxic biochemical cascade that occurs during 
and after cerebral ischemia is complex and may be initiated by a number of factors [12, 
13]. The detailed mechanisms are further explained in multiple reviews [14-17].   
 
In addition to the ischemic event itself, injury continues to occur during and after 
reperfusion. Thus, the cerebral blood flow following resuscitation is of great importance. 
There are a number of studies that examined reperfusion injuries, including the 
hypothesis that an increase in glutamatergic transmission during reperfusion, which is 
supported by in vitro work [18], may intensify the excitotoxic injury caused during 
ischemia [19]. Another widely suggested explanation of reperfusion injury involves 
oxygen radicals [20, 21], suggesting that the return of oxygen to the brain allows harmful 
enzymatic oxygenation reactions to occur [22].  
3 
Neurologic injury is a crucial contributor to the morbidity and mortality of post-CA 
patients [23], thus, it is important to understand the mechanisms underlying the 
ischemic/reperfusion injury and how to assess and monitor the level of injury following 
CA.   
 
1.1.3   Functional Outcome and Neurological Recovery Assessment  
The cerebral cortex is among the most vulnerable regions of global cerebral ischemia 
[24]. Extensive bilateral cortical or thalamocortical damage may result in problems with 
arousal and consciousness [25], which is likely why many post-CA patients remain 
comatose for some time. The brainstem is more tolerant to ischemic damage, resulting in 
the preservation of sensory motor reflexes in many patients, even in a comatose state [4]. 
It is important that physicians assess the injury level and neurological recovery of post-
CA patients in terms of functional outcome, however this is complicated when patients 
remain comatose.  
 
The Glasgow coma scale (GCS) is a clinical scale that was developed to evaluate the 
depth and duration of comatose patients or patients with impaired consciousness [26], 
however, it has also been used in the assessment of comatose post-CA patients [2, 27-33].  
The scale measures three behavioral features – motor responsiveness, verbal performance 
and eye opening. Each category is given a score from 1 to 5. Often the scores are 
summed to give a total score from 3 (worst) to 15 (best), however, the original creators of 
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the scale suggest that each category should be assessed on an individual basis for clinical 
use [33]. 
 
The cerebral performance category (CPC) scale was created [34] and modified [35] to 
uniformly evaluate cerebral performance. The scale has 5 levels, with CPC 1 representing 
the best performance and 5 representing the worst (Table 1.1). Many groups have used 
CPC to evaluate functional outcome after CA [27, 34, 36-39] where in most cases, but 
not all [40], CPC scores of 1 or 2 represent patients with good outcome and 3-5 are poor 
outcome [23, 41, 42].  
 
Table 1.1 Cerebral Performance Categories 
CPC Level Cerebral performance description  
CPC 1 Good cerebral performance  
CPC 2  Moderate cerebral disability 
CPC 3  Severe cerebral disability 
CPC 4 Persistent vegetative state  
CPC 5 Brain death or clinical death  
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The neurologic deficit scale (NDS) is used to assess functional recovery of post-CA rats, 
and was developed based on human neurological examination and animal functional 
outcome scales for global ischemia models [43-45]. The scale evaluates performance in a 
number of behavioral tests including gait coordination, righting reflex and pupillary light 
reflex (Table 1.2). The 72 hour NDS score is generally used to determine final functional 
outcome in asphyxia CA rat models. An NDS ≥ 60 is generally defined as good 
functional outcome and NDS < 60 is defined as poor functional outcome [46]. Animals 
with good functional outcome are mobile and have appropriate responses to stimuli 
whereas animals with poor functional outcome are immobile and have minimal stimuli 
reactions. This scale has been validated in post-CA rat models [47, 48].  
 
Table 1.2 Neurological Deficit Scale Scoring 
Arousal: 
Alerting: Normal (0)/ Stuporous (5) / Comatose (0) 
Eye Opening: Open spontaneously (3) /  Open to pain (1) / Absent (0) 
Spontaneous Respiration: Normal (6) /  Abnormal (3) / Absent (0) 
Total Score : 19 
Brainstem Function:  
Olfaction: Present (3) / Absent (0) 
Vision: Blinks to threat (3) / Absent (0) 
Pupillary Light Reflex: Present (3) / Absent (0) 
Corneal Reflex: Present (3) / Absent (0) 
6 
Startle Reflex: Present (3) / Absent (0) 
Whisker Stimulation: Present (3) / Absent (0) 
Swallowing: Present (3) / Absent (0) 
Total Score: 21 
Motor Assessment: 
Strength: Normal (3) / Weak movement (1) / No movement (0) 
(Each side tested and scored separately) 
Total Score: 6 
Sensory Assessment: 
Pain: Brisk withdrawal (3) / Weak withdrawal (1) / No movement (0) 
(Each side tested and scored separately) 
Total Score: 6 
Motor Behavior: 
Gait coordination: Normal (3) / Abnormal (1) / Absent (0) 
Balance Beam Walking: Normal (3) / Abnormal (1) / Absent (0) 
Total Score: 6 
Behavior: 
Righting Reflex:  Normal (3) / Abnormal (1) / Absent (0) 
Negative Geotaxis: Normal (3) / Abnormal (1) / Absent (0) 
Visual Placing: Normal (3) / Abnormal (1) / Absent (0) 
Turning Alley: Normal (3) / Abnormal (1) / Absent (0) 
Total Score: 12 
7 
Seizures: 
Seizures: No seizure (10) / Focal seizure (5) /  Generalized seizure (0) 
Total Score: 10 
 
 
1.2   Targeted Temperature Management  
1.2.1   Hypothermia  
Targeted temperature management (TTM), which involves cooling the body to a 
hypothermic state, has been regarded as an effective treatment following out-of-hospital 
CA to improve survival and functional outcome [49]. While the specific mechanisms 
underlying the neuroprotection benefits of TTM are not fully elucidated, it is believed 
that the cooling reduces the functional requirements of the cells, thereby protecting them. 
Normothermic cerebral neurons cannot last more than 5 mins in an ischemic anoxic state, 
thus, TTM is believed to improve neurological functional outcome likely by reducing the 
cerebral oxygen requirements, preventing free-radical injury and cell membrane damage, 
or inhibiting the release of damaging neurotransmitters [50].  
 
The ischemic brain has been shown to be highly sensitive to temperature fluctuations [51], 
which has a significant impact on treatment during the early recovery following 
resuscitation. The temperature sensitivity of brain injury is likely modulated by increased 
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levels of excitatory amino acids and free radicals, ischemic depolarization, increased ion 
flow, pathological events, and post-ischemic microvascular abnormalities [52-58]. Mild 
hypothermia, which decreases cerebral metabolic rate of oxygen (CMRO2) consumption 
[59], has been shown to improve survival and functional outcome following CA in 
human [23, 41, 60-67] and animal studies [68-73].  
 
Though it is well-established that mild hypothermia improves survival and functional 
outcome following CA, there is still controversy regarding the various induction factors, 
including start time, length of treatment, degree of treatment, and method of cooling. 
Various studies indicate that hypothermia should be initiated immediately after 
resuscitation, beginning in the field and that a delay of even 15 min could reduce or 
eliminate the neuroprotective effect [71], while others suggest that a delay before cooling 
may also be beneficial [74-78]. Additionally, there has been uncertainty regarding the 
degree of hypothermia and length of application that are most beneficial. The 
International Liaison Committee on Resuscitation recommended TTM of 32-34°C for 12-
24 hours [79]. However, one study has demonstrated that TTM of 36°C is no less 
beneficial than TTM of 33°C [80]. Thus, while the beneficial effects of TTM have been 
thoroughly demonstrated, the details of treatment are not unanimously agreed upon.  
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1.2.2   Hyperthermia and Pyrexia 
Hyperthermia has been shown to worsen brain damage in animals [54, 55, 57, 81] and 
humans [52, 56, 58, 82, 83] in post-CA recovery. Though hypothermia is now commonly 
used as a means of neuroprotection, it often results in rebound hyperthermia (body 
temperature > 38.5°C) within 24h following rewarming from TTM [83], with a reported 
prevalence ranging from 22-74% of patients treated with TTM [84, 85]. Studies have 
shown that in patients who experienced rebound hyperthermia, outcome was worsened 
[83] and a higher maximum temperature was associated with worse outcome [56]. 
Despite efforts to finely control temperature during recovery, pyrexia (≥ 37.6°C) is 
common in both TTM and non-TTM patients [86] and also tends to worsen outcome in 
non-TTM patients [58]. Thus, whether pyrexia occurs spontaneously from a 
normothermic condition during recovery or as a result of TTM rewarming, it is well 
documented that fever is harmful to recovery [49].  
 
1.3   Current Prognostic Tools 
1.3.1   Importance of Early Prognostication 
Early prognostication shortly after resuscitation from CA is essential as it can help guide 
treatment, reasonably distribute resources and counsel family regarding likely outcome. 
Current prognostic markers have been verified in normothermic patients however, their 
reliability in hypothermic patients has not been thoroughly studied and verified.   
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Overall, many CA patients remain comatose during early recovery, which makes 
prognostication of functional outcome and treatment planning difficult. It is crucial to 
properly identify those patients in a comatose state following CA that have a chance to 
recover versus those who will never awaken. Ideally, reliable prognostication would be 
possible immediately after resuscitation, while most patients are still comatose and under 
TTM. Currently, there is no tool that can reliably achieve this prediction under TTM. 
Early prognostication would be a major step towards optimizing treatment for each 
individual patient.   
 
1.3.2   Ideal Prognostic Marker Features  
The prognosis tools need to reliably predict outcome following CA during the early 
recovery period in an objective manner under TTM conditions. This primarily means that 
the tool cannot be largely confounded by sedatives or paralytics or by temperature. 
Additionally, the prognostic tool should robustly predict both good and poor outcome 
with high sensitivity and specificity. Further, the prognostic test must be objective, 
simple to implement in a wide range of medical centers (i.e. does not require highly 
specialized training or equipment), and time and cost effective. Ideally, the prognostic 
tool would generate a quantitative value for the patient, which could be compared to a 
numeric cutoff point to predict good or poor outcome.  
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1.3.3   Current Tools and Limitations 
Awakening from a coma is the best predictor of good outcome, however, a well verified 
early recovery prognostic indicator for good outcome that can be measured while the 
patient remains in a coma, has not yet been established. Conversely, there are a number 
of methodologies to predict poor outcome for normothermic comatose patients, with 
somatosensory evoked potentials (SSEP) being the most widely accepted.  
 
A number of prognostic tools have been developed to predict outcome following CA 
under normothermic conditions including bedside clinical assessment, 
electroencephalogram (EEG) monitoring, biomarkers and somatosensory evoked 
potentials (SSEP). However, many of these techniques have major limitations such as 
requiring highly subjective manual pattern recognition and impedance from the sedation 
that is necessary for TTM [87, 88]. Additionally, the prognostic value of these techniques 
has not been convincingly verified under TTM.   
 
Clinical Examination 
Clinical examination is one of the oldest prognostic tools for post-CA comatose patients. 
These exams are beneficial as they are universally available and relatively simple for 
physicians to perform. One common clinical examination is coma or cerebral 
performance scoring using scales such as GCS [2, 89-91]. Reflex tests such as brainstem 
reflexes that test various cranial nerves [92, 93] like the pupillary reflex (nerves II and 
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III), corneal reflex (nerves V and VII), and gag and cough reflex (nerves IX and X) are 
also common. Vestibular signs may also be tested using oculocephalic or oculovestibular 
reflex tests [94]. Finally, observance of seizures or myoclonus status (sudden muscular 
contractions) [31, 95-97] has been used in the assessment of patient prognosis.  
 
Based on 5 studies [29, 31, 91, 96, 98], the most useful clinical tests at 24 hours post-CA 
in predicting poor outcome are absent corneal reflexes, absent pupillary reflexes, absent 
motor response and absent withdrawal to pain [94].  
 
However, clinical examination has major downsides, particularly under TTM. One major 
drawback is that sedatives and paralytics must be temporarily stopped to successfully 
perform clinical examinations. Additionally, no clinical tests are able to predict good 
outcome of comatose patients or accurately predict outcome immediately after 
resuscitation [94].  
 
Electroencephalogram (EEG) 
EEG is one of the most widely used tools in post-CA patient monitoring [99, 100]. EEG 
represents the summation of neuronal electrical activity within a spatial region and has 
distinct frequency bands, which have been distinguished based on clinically relevant 
values: delta (< 4 Hz), theta (4-8 Hz), alpha (8-15 Hz), beta (16-30 Hz), and gamma (> 30 
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Hz), each representing different cerebral responses and activities [101, 102]. EEG is 
useful in assessing ischemic damage post-CA due to the typical changes in EEG 
amplitude and frequency of these relevant bands [103].  
 
Amplitude integrated EEG (aEEG), a processed EEG that weighs the signal based on 
amplitude, has been shown to have prognostic value when applied during the 
normothermia state after rewarming from TTM, approximately 37h after CA [104]. In the 
first 4-8h after beginning the EEG recording, continuous aEEG was correlated with good 
outcome [104, 105], however, it is flat for most patients, which held no prognostic value 
[105] so the usefulness of this association is limited.  
 
Continuous EEG (cEEG) is another form of EEG measurement. cEEG has been shown to 
hold prognostic value during TTM (approximately 12 hours after CA), suggesting that 
background reactivity of cEEG is not impacted by sedation or temperature [106]. 
However the cEEG interpretation is still done manually and is therefore subjective and 
laborious. Another study of cEEG in post-CA TTM patients demonstrated that when 
cEEG was graded on a scale of 1-3 (1=benign, 3=severe), scores of 1 and 3 were 
associated with good and poor outcome, respectively, during hypothermia and 
normothermia [107]. However, there were major cost and labor requirements to employ 
this cEEG monitoring method.  
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Thus, there are various drawbacks to the aforementioned EEG prognostic methods, 
including the confounding effects of sedation, ineffectiveness during the early recovery 
period, and the subjective and laborious nature of the signal interpretation. Further, it has 
been suggested that EEG is most useful for prognostication at 24h+ after resuscitation 
[108, 109], which eliminates its value in tracking early recovery while under TTM. To 
circumvent these limitations, quantitative EEG measurements that do not require manual 
pattern recognition or interpretation have been developed.  
 
Based on the notion that cerebral recovery following CA is represented by the EEG 
information content, an objective, quantitative EEG marker, information quantity (IQ), 
was developed to track post-CA recovery [110]. The IQ measure is representative of the 
entropy of the EEG signal. However, since EEG contains multiple frequency bands that 
represent various brain functions, a modified IQ value was developed, sub-band IQ (SIQ), 
which represents the IQ value within each clinical sub-band (delta, theta, alpha, beta, and 
gamma) [111]. Both of these quantitative measures have been shown in numerous animal 
studies to reliably track neurological function in the early post-CA recovery period under 
TTM [46, 110-115]. 
 
Biomarkers 
Following CA, biomarkers such as the concentration of neuron-specific enolase (NSE) 
from serum or cerebral spinal fluid (CSF) change, and thus have been recognized as 
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possible predictors for functional outcome [116-123]. Increased levels of CSF NSE, 
which is primarily located in neurons and neuroectodermal cells, has been associated 
with poor neurologic outcome in patients with anoxic encephalopathy [117, 122, 124], 
however, serum NSE is predominantly used for CA patients, for convenience and safety 
reasons. Multiple studies have demonstrated that higher levels of serum NSE are 
associated with poor neurologic outcome following CA [116, 125, 126], however, at least 
one study was unable to reproduce this finding [124]. Additionally, the NSE cutoff level 
and ideal sample time have not been validated in larger studies [127, 128]. Thus, the 
serum NSE biomarker presents limitations in the prognosis of post-CA patients.  
 
Somatosensory Evoked Potentials (SSEP)  
SSEP following CA involves nerve stimulation and non-invasive measurement of the 
corresponding responses from the somatosensory cortex, which evaluates the 
somatosensory pathway and transmission within the central nervous system and 
brainstem [50]. The technique measures the initial cortical responses after repetitive and 
alternating stimulation of the median nerves of both wrists, though other stimulation and 
recording sites may also be used. The negative cortical response 20ms after stimulation, 
named the N20 peak, is commonly used in post-CA prognostication. The bilateral 
absence of the N20 peak robustly predicts poor functional outcome [42, 88, 129-136]. 
Further, the bilateral absence of N20 has been shown to predict nonawakening from coma 
following conditions other than cardiac arrest [137]. Thus, SSEP has been shown to hold 
great prognostic value for poor outcome cases following CA.  
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1.4   Somatosensory Evoked Potentials (SSEP)  
While a number of studies have been conducted to validate existing prognostic markers 
under TTM, there have been inconsistent results across studies. Further, progress in the 
development of a quantitative and objective prognostic method for post-CA recovery has 
been limited. While a quantitative SSEP (qSSEP) algorithm has been developed, it has 
not been validated under temperature management conditions.  
 
1.4.1   SSEP is one of the Best Predictors for Poor Outcome  
Following cardiac arrest, patients are often in a state of comatose, making previously 
standard clinical examinations difficult and unreliable. Electroencephalogram (EEG) has 
been a common technique to observe brain activity in comatose patients for a long time, 
however, more recently somatosensory evoked potentials (SSEPs) have been proven to 
be more reliable in predicting outcome [133, 134]. Further, with TTM becoming an 
increasingly standard treatment following out-of-hospital CA, EEG and clinical 
examination are becoming less reliable, as the sedation and muscle relaxants required for 
hypothermia confound the results of these methodologies. Thus, SSEP has come to the 
forefront as a better prognostic measurement, as it has a simple bedside setup, is 
relatively non invasive, and is not confounded by sedative drugs [88].  
 
SSEP has been suggested as one of the most reliable tools to predict functional outcome 
following CA in normothermic human patients [133, 134]. While there are numerous 
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features of SSEP that can be extracted, the bilateral absence of the short-latency N20 
peak (the negative cortical peak occurring approximately 20ms after stimulation) has 
been regarded as a reliable indicator for poor functional outcome following CA [133, 134, 
136] with TTM [42, 88, 129-132, 135]. However, its reliability has recently been 
challenged, as a few patients have been reported to have positive functional outcomes 
after having bilaterally absent N20 peaks [138, 139], though some experts have deemed 
these cases insufficient to counter the prognostic value of SSEP [140]. Further, while the 
bilateral absence of N20 peaks indicates poor outcome, the presence of N20 peaks does 
not suggest good outcome. Thus, it is important to develop a threshold for present SSEP 
peaks to predict good outcome. Additionally, SSEP is currently used for poor outcome 
assessment by the bilateral absence of N20 peaks, however, this evaluation is very 
subjective, even among highly trained experts [141, 142].  
 
Additionally, there are conflicting views among different groups regarding the ideal 
window of time in which SSEP measurements have the highest prognostic value. Some 
groups suggest that SSEPs should be measured after 24 hours post-CA [143, 144], while 
others suggest that 1 hour post-ROSC leads to the best predictive ability [145]. It has 
been argued that SSEP recordings before 24 hours are not useful because SSEPs may be 
confounded by impaired cerebral perfusion and reperfusion damage [145]. However, 
since excitotoxic-ischemic cascades begin shortly after injury, many treatment plans, 
namely TTM, are most effective when applied immediately after resuscitation, so early 
evaluation is crucial.  
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Yet, SSEP measurements still hold great benefits in prognosis following CA as these 
measurements are repeatable, non-invasive, unimpeded by sedation, and present multiple 
characteristics that can be quantified, such as latency, amplitude, and shape [88, 146]. 
 
1.4.2   Reliability of SSEP Under Targeted Temperature Management 
The validation of SSEP under TTM, an increasingly standard treatment, is necessary. 
Some studies have suggested that hypothermia decreases the prognostic value of the 
standard SSEP tests in the early stages of recovery after cardiac arrest [128, 139], while 
others have demonstrated that SSEP remains reliable for poor outcome prediction under 
hypothermia [88], though there is inconsistent and relatively limited data in these areas to 
be reliably conclusive.   
 
Most studies comparing SSEP in hypothermic patients to normothermic patients have 
found that bilaterally absent N20 remains reliable in predicting poor outcome. In one 
study comparing 14 hypothermic to 27 normothermic patients who received SSEP days 
1-3 after CA, bilaterally absent N20 was an invariable predictor of poor outcome [132]. 
In another study comparing 30 hypothermic and 27 normothermic patients, 3 
hypothermic and 8 normothermic patients had bilaterally absent N20, none of whom 
regained consciousness [135]. Further, a study of 46 hypothermic patients who received 
SSEP showed that 47.4% of the patients with poor outcome had bilaterally absent N20 
responses [129]. In another study with 75 patients undergoing hypothermia, all patients 
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had SSEPs recorded during hypothermia and again in 34 patients during normothermia 
after rewarming. During hypothermia, 13 patients had bilaterally absent N20, all of 
whom had poor outcome. This study also demonstrated that bilateral absence of N20 
during hypothermia is a good predictor for bilateral absence of N20 after rewarming 
[130], which is an important finding, as earlier testing can improve the titration of the 
hypothermia treatment. Finally, in another CA study, 30 patients had SSEPs recorded 
approximately 72hrs after being rewarmed from hypothermia. Fourteen of these patients 
had bilaterally absent N20 and all died without regaining consciousness [147].  
 
However, there are studies that have rare false positive cases that have caused concern 
regarding the method’s reliability under TTM. In a study comparing SSEP of 110 
hypothermic patients (33°C) to 94 normothermic patients (36°C), there was a false 
positive rate of 2.6% for bilaterally absent SSEP N20 [148]. Similarly, in a meta-analysis 
by Sandroni et al, there were no patients in the included studies that recovered when the 
N20 was bilaterally absent during TTM but in 538 patients that had SSEP recordings 
following rewarming, there was 1 false positive [149].  
 
Overall, while SSEP results have been shown to aid the prognostic process after 
resuscitation, the results have led experts to caution against relying on bilaterally absent 
N20 responses in making withdrawal of life support treatment decisions.   
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1.4.3   Prognostic Value of SSEP for Good Outcome Prediction 
While the bilateral absence of N20 SSEPs robustly predicts poor outcome in post-CA 
patients, the presence of unilateral or bilateral N20 peaks does not predict good outcome. 
Currently, there are no verified SSEP measures that predict good functional recovery of 
comatose patients. It would be useful to have a quantitative measure of SSEP with a 
defined cutoff point, which could robustly dichotomize both good and poor outcome.  
 
1.4.4   Quantitative SSEP is an Objective Prognostic Indicator  
As previously mentioned, an objective and reliable measurement of SSEP is necessary to 
eliminate the variability in data interpretation and to simplify the results. A quantitative 
measure of SSEP could achieve these requirements, if verified to predict final outcome 
under temperature management.  
 
Amplitudes and Latencies  
Perhaps the most obvious method of quantification of SSEP signals is the calculation of 
peak amplitude and latency. Multiple groups have studied the amplitude and latency of 
SSEP under temperature management in non-CA patients and animals [150-159] and 
under normothermic and hypothermic conditions in post-CA patients [135]. Overall, 
these studies demonstrate that hypothermia increases peak latency, however, there were 
inconsistent results regarding the effect of hypothermia on SSEP amplitude. The 
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mentioned studies observed increases, decreases or no change in amplitude, based on the 
recording site and condition of the subject. Additionally, one study found that under 
hyperthermic conditions, higher temperatures decrease peak latency and have no 
significant effect on peak amplitudes [154].   
 
In post-CA patients, SSEP amplitude and latency have been studied by a few groups, but 
their prognostic values have not been extensively examined. One group found that post-
CA patients treated with hypothermia had significantly prolonged cortical N20 peaks 
compared those treated with normothermia [135, 160]. Additionally, the same study 
found that N20 amplitudes were not significantly different between temperature groups 
and was not associated with functional outcome. However, this study lacked the 
statistical power to analyze the correlation of N20 latency or amplitude with outcome to 
determine their prognostic value. Another study found that normothermic patients with 
hypoxic-ischemic damage, defined by CPC > 2 at 1 year, had significantly prolonged 
N20 latency and lower N20 amplitude compared to those without hypoxic-ischemic 
damage [160]. Finally, a study of post-CA patients treated with TTM found a threshold 
amplitude, 0.62uV, at which lower amplitudes were associated with poor outcome [161]. 
Thus, SSEP amplitude and latency hold possible prognostic value, though they need to be 




Phase Space Area 
A novel quantitative SSEP (qSSEP) technique has been developed and tested in rats 
[145]. This qSSEP metric is important, not only because it helps to eliminate the 
subjective nature of SSEP interpretation, but it has also been shown to predict good 
outcomes in post-CA rats, whereas standard manual interpretation of absent N20 
responses (N10 responses in rats) only predicts poor outcome.  
 
The quantitative analysis uses the phase space curve (PSC), a plot of the first derivative 
against magnitude, to compute the phase space area (PSA), which is indicative of signal 
power and quantified to obtain a single PSA value that represents the functionality of the 
somatosensory pathway [145]. The PSC differs from standard SSEP waveform analysis 
in that it incorporates multiple peak characteristics including peak amplitudes, slopes, and 
interpeak latency [145]. In the initial study by Madhock et al, PSA increased over the 
early recovery period (4 hours after ROSC) and while the animals with good and bad 
outcome (defined by NDS scores) were not differentiable by PSA in the first hour after 
ROSC, they did have significantly different PSA values in the following 3 hours of early 
recovery (85-190 min post-ROSC) with an outcome prediction accuracy of 80-93% 
(p<0.05) and 78% sensitivity to good outcomes with 83-100% specificity [145]. Further, 
the early recovery PSA (within the first 4 hours after ROSC) successfully predicted 72hr 
neurologic outcomes, which suggests that early recovery SSEP measurements hold 
significant prognostic value [145]. To compare this method to standard SSEP analysis, 
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N10-P15 peak-to-peak amplitude was shown to have similar trends as the PSA, but they 
were less separated between the outcome groups and had a higher variability.  
 
Thus, this qSSEP method provides a technique that doesn’t require sophisticated peak 
detection but can still track brain injury and is a useful predictor to differentiate between 
good and poor outcome [145]. One major limitation of the current information on this 
method is that this study was done using normothermic animals, and needs to be repeated 
with temperature management to validate the qSSEP method in under TTM. While 
qSSEP still needs to be validated in animals under hypothermia after CA, it shows 
promise as an objective early recovery prognostic indicator.  
 
1.4.5   Conclusion 
Prognosis of functional outcome while patients are comatose following resuscitation after 
CA remains an important area of clinical research. Due to the subjective nature of SSEP 
interpretation, current prognosis markers are inadequate in providing reliable information 
to dictate treatment options and medical decisions, particularly with TTM becoming a 
widely used treatment post-CA. While many groups have demonstrated that bilaterally 
absent N20 responses remain reliable in predicting poor outcome with TTM treatment, 
the results are not convincing to all experts. Further, development of a quantitative SSEP 
measurement has been initiated, however, its validation under temperature management 
is necessary. Overall, the prognostic value of SSEP can be greatly improved by the 
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validation of an objective and reliable method under TTM administration following 










CHAPTER 2: QUANTITATIVE SOMATOSENSORY 
EVOKED POTENTIALS DURING EARLY RECOVERY 
ARE ASSOCIATED WITH FUNCTIONAL OUTCOME 
AFTER CARDIAC ARREST WITH TEMPERATURE 
CONTROL 
2.1   Introduction 
Despite advances in pre-hospital care including cardiopulmonary resuscitation (CPR) 
technique, out-of-hospital cardiac arrest (CA) continues to result in major public health 
implications [1]. Targeted temperature management (TTM) is currently recommended as 
a standard neuroprotection method for comatose patients following CA and has been 
shown to improve survival and functional outcome [49]. Fever is common during 
recovery [86] and tends to worsen outcome [49, 58]. Overall, many CA patients remain 
comatose during early recovery, which makes prognostication of functional outcome and 
treatment planning difficult. Thus, there is a great need for an objective prognostication 
method to predict functional outcome post-CA during the early recovery period. 
 
A number of prognostic tools have been developed to predict outcome following CA 
under normothermic conditions, however, many techniques are impeded by the sedation 
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that is necessary for TTM [87, 88]. The bilateral absence of the short-latency 
somatosensory evoked potential (SSEP), N20, has been regarded as a reliable indicator 
for poor functional outcome following CA [133, 134, 136] with TTM [42, 88, 129-132, 
135], though still with controversy [138-140]. Further, while the bilateral absence of N20 
peaks indicates poor outcome, the presence of N20 has low specificity for good outcome. 
Thus, it is important to develop a threshold for existing SSEP peaks to predict good 
outcome. SSEP hold great prognostic benefits following CA as these measurements are 
repeatable, non-invasive, unimpeded by sedation, and present multiple quantifiable 
characteristics such as latency, amplitude, and contour [88, 146]. 
 
The N7 and N10 rat SSEP peaks, which represent the negative cortical responses at 7 and 
10ms after stimulation, are analogous to the N18 and N20 peaks in humans [145]. The rat 
N7 peak has been shown to recover following CA though its prognostic value has not 
been identified [162].  Despite recent controversy regarding the value of various degrees 
of TTM [80, 163], the prognostic value of the presented SSEP markers under TTM of 
33°C is important, as TTM of 33°C remains a current standard treatment for post-CA 
patients, as recommended by international guidelines [49, 79] and has been extensively 
studied by many groups [23, 41, 51, 67, 164, 165], including our own [46, 112-114, 166].  
 
In this study, we used an established asphyxial-CA rat model to test the hypothesis that 
SSEP latency and amplitude can be quantified during early recovery from CA as 
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objective markers to predict functional outcome following resuscitation under TTM 
conditions.   
 
2.2   Materials and Methods  
2.2.1   Animals  
A total of 21 adult male Wistar rats (378±8g) were randomly assigned to one of three 
temperature groups (n=7 per group): hypothermia (33±1°C), normothermia (37±0.5°C), 
or hyperthermia (39±0.5°C). Each animal underwent 7 min asphyxial-CA followed by 
immediate temperature manipulation, according to their assigned group. An additional 14 
rats were assigned to a sham group, which underwent the same experimental procedures 
except for CA and resuscitation. All experiments were approved by the Institutional 
Animal Care and Use Committee at Johns Hopkins University.  
 
2.2.2   Electrode Implantation 
Approximately 1 week prior to the date of CA, 5 screw electrodes (Plastics One, Roanoke, 
VA) were cortically implanted in each rat’s brain to record the SSEPs [145, 162]. Four 
electrodes were placed over the somatosensory cortex in the regions that are 
topographically associated with the forelimbs and hindlimbs, and one ground electrode 
was placed near the parasagittal right frontal lobe. The electrodes were placed above the 
dura mater such that they did not penetrate the brain. The electrodes were held in place 
28 
with a plastic pedestal and dental cement and the skin was closed around the implant with 
sutures.  
 
2.2.3   Cardiac Arrest, SSEP and Early Recovery  
The rats underwent CA and resuscitation as previously described [46, 110, 113, 145]. 
Briefly, the rats were anesthetized with 1.5% vaporized isofluorane in 1:1 O2:N2 and 
then a tracheal intubation was performed. A mechanical ventilator (Harvard Apparatus 
Model 553438)	continued to administer the isofluorane mixture with the following 
ventilation parameters: 50 breaths/minute respiratory rate, 8ml/kg tidal volume, and 3cm 
H2O positive expiratory end pressure. The femoral artery and vein were then cannulated 
(Intramedic Non-Radiopaque Polyethylene Tubing PE-50 catheters, PE 50, Becton 
Dickinson) to monitor the mean arterial pressure (MAP) and obtain blood samples, and to 
deliver drugs, respectively. Baseline arterial blood gases (ABGs) were measured via the 
arterial cannulation. A baseline SSEP was recorded for 15 min followed by a 5 min 
isofluorane washout. The washout period consisted of 2 min of 100% oxygen followed 
by 3 min of room air, during which a bolus injection of vecuronium (2mg/kg) was given 
intravenously to induce muscle paralysis in the rats. The ventilator was then disconnected 
and the tubes of the breathing circuit were clamped to induce global asphyxia. CA was 
achieved when pulse pressure < 10mmHg. Immediately following 7 min of CA, 
cardiopulmonary resuscitation (CPR) was performed with resumption of ventilation 
(respiratory rate: 40 breaths/min, tidal volume: 8ml/kg, positive expiratory end pressure: 
0cm H2O), 100% oxygenation, sternal chest compressions (200 compressions/min), 
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intravenous epinephrine (0.005 mg/kg) and intravenous sodium bicarbonate (1mmol/kg) 
until the return of spontaneous circulation (ROSC), which was defined as pulse pressure 
> 60mmHg. Hyperventilation was induced for 10 min using the ventilation parameters 
(respiratory rate: 65 breaths/min, tidal volume: 8ml/kg, positive expiratory end pressure: 
0cm H2O), at which point the respiratory rate was switched to 55 breaths/min for 10 min 
and subsequently 50 breaths/min. ABGs were measured at 10, 20 and 40 mins after 
ROSC. Approximately 2 hours following ROSC, animals were extubated. All animals 
were closely monitored throughout the duration of the experiment for any signs of 
distress or pain. Stimulation and SSEP recordings were restarted at 30 minutes after 
ROSC and were maintained in 15 min intervals until 4 hrs after ROSC. During the 
recovery period, up to 0.5% isofluorane was used when SSEP recordings were restarted  
(30 min post-ROSC), dependent on the rat’s recovery, due to the potential discomfort of 
the nerve stimulation [145]. 
 
2.2.4   Temperature Management  
For the hypothermia group, cooling began immediately after ROSC and the target 
temperature was reached within 10 mins. Cooling was achieved using an alcohol/water 
mist and a small electric fan. The core temperature was maintained at 32-34°C for 4 hrs. 
Rewarming began after 4 hrs of hypothermia until normothermia was reached over a 
period of 2 hrs. For the hyperthermia animals, warming began immediately after ROSC 
until the target temperature was reached, within 15 minutes. Warming was done using a 
heating lamp and heating pad (Thermalet TH-5, model 6333, Physitemp Instruments, 
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Clifton NJ). Hyperthermia, 38.5-39.5°C, was maintained for 4 hrs after ROSC and 
passive cooling occurred over a period of 2 hrs until normothermia was reached. The core 
temperature of the normothermia rats was maintained at 36.5-37.5°C for 4 hrs after 
ROSC using a heating pad. A neonatal incubator was used for the following 24 hrs to 
prevent spontaneous hypothermia [114]. 
 
2.2.5   Neurologic Evaluation  
The neurological function of rats following CA was determined using the Neurologial 
Deficit Scale (NDS), which has been well verified in the evaluation of motor, sensory and 
brainstem function [46, 113, 114]. Animals were given an NDS score ranging from 0 
(worst) to 80 (best). The NDS was recorded by a trained and blinded researcher 2 hrs 
after temperature modulation, and at 24, 48 and 72 hrs following ROSC, where the 72 hr 
score represents the endpoint functional outcome [154, 162]. Based on previous 
publications, the animals were grouped into good and poor outcome groups based on 
final NDS score such that good outcome animals represented those with some mobility 
and quick response to stimuli [46, 113, 114, 145, 162]. Thus, the 72 hr NDS score was 
used to define the final functional outcome as either good (72 hr NDS ≥ 60) or poor (72 
hr NDS < 60) [46]. Animals that died before 72hrs were given a 72hr NDS score of 0. 
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2.2.6   SSEP Signal Sampling and Analysis  
The median nerves in the forelimbs of the rats were stimulated using subdermal needle 
electrodes and the SSEPs were recorded from the screw electrodes in the respective 
contralateral hemisphere. A pulse generator provided 200-usec 6mA pulses to the needle 
electrodes at a frequency of 0.5Hz. The SSEP signals were recording using the TDT 
System3 data acquisition system (Tucker-Davis Technologies, Alachua, FL). The SSEP 
data was sampled at a frequency of 6.1kHz and was passed through an amplifier before 
reaching the computer. SSEPs were recorded on the day of the experiment for 15 min 
before CA (baseline) and for 15 min intervals, beginning 30 min post-ROSC until 4 hrs 
post-ROSC. The SSEPs were also recorded for 15 minutes at 24, 48 and 72 hrs post-
ROSC, with 1.5% isofluorane.  
 
The SSEP signals were averaged over 450 sweeps during the peak detection process. An 
algorithm in MATLAB was used to calculate the peak amplitudes and latencies. 
Specifically, the N10 (N10-P15 peak-to-peak) amplitude and N7 and N10 latencies were 
determined. The N7 and N10 peaks represent the negative responses that occur 
approximately 7 and 10ms after stimulation, while the P15 peak represents the positive 
response 15ms after stimulation. The N7 and N10 latencies were measured as the time to 
the N7 or N10 peak, respectively, from the time of stimulation. The amplitudes and 
latencies were normalized by the baseline values recorded before CA. Animals with 
abnormal baseline SSEPs (bilaterally distorted N10 and P15 peaks) were excluded from 
the analysis. 
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2.2.7   Statistical Analysis  
All statistical analyses were done using the SPSS Statistics computer package (IBM 
SPSS Statistics v22, Armonk, NY). A nonparametric Kruskal-Wallis test was used to 
compare the 72 hr NDS between temperature groups, which are reported as (median (25th, 
75th percentiles)). The N7 and N10 amplitudes and latencies were compared among 
outcome groups using a general univariate analysis, while they were compared among 
temperature groups using repeated measures analysis of variance (ANOVA). Pearson 
correlation coefficients were determined using bivariate analyses to determine the 
relation between SSEP markers and 72 hr NDS. Receiver operating characteristic curves 
were generated to identify N10 amplitude cut-off points at 100% specificity and 
maximum sensitivity with an area under the ROC curve that is significantly different 
from the 0.5 reference line. Aggregate latency or amplitude considered all values at each 
time point over the entire 4 hr early recovery period for all animals within a particular 
group. A p < 0.05 was considered statistically significant. 
  
2.3   Results  
2.3.1   Temperature Management, ABG Monitoring and NDS 
The core temperature of all animals was well controlled throughout experiments 
(hypothermia: 33.8±0.1oC, normothermia: 36.9±0.1oC, hyperthermia: 38.5±0.05oC). The 
target temperature for each group was reached within 12 ± 2 mins and maintained for the 
4 hr early recovery period (Fig. 2.1). Baseline arterial blood gases (ABG) were not 
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significantly different among temperature groups (p>0.05) (Table 2.1). The baseline 
animal weight was not significantly different between temperature groups (p>0.05) 
(Table 2.1). The 72 hr NDS score was significantly higher in the hypothermia group [74 
(74,77)] than the normothermic group [68 (49,72)] (p<0.01), which was significantly 
higher than the hyperthermic group [0 (0, 58)] (p<0.01), in which less than half the 
animals survived to 72hrs post-ROSC. The 72hr survival rates for normothermia, 




Figure 2.1. The animal temperature (mean±S.E.M.) was well maintained throughout the duration of the experiment. The 4 hr 
temperature management period is indicated between the dashed lines.  
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Table 2.1 Baseline ABG and Weight Data 
 Hypothermia Normothermia Hyperthermia 
pH 7.42±0.02 7.43±0.01 7.39±0.02 
pCO2 46.8±3.6 42.6±3.0 48.5±1.9 
HCO3- 29.7±0.9 28.1±1.6 29.6±1.0 
SO2 99.7±0.3 99.7±0.3 100±0.0 
Weight (g) 366±7 370±4 399±20 
 
 
The evolution of the SSEP pattern was similar in animals, such that the peaks recovered 
towards the original baseline shape over time during the early recovery period (Fig 2.2A-
C). The SSEP recordings showed similar shape but variable peak latencies and 
amplitudes under different temperature conditions (Fig. 2.2D).  
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Figure 2.2. Representative time evolution of SSEP recording throughout the experiment 
in (A) Normothermia (B) Hypothermia and (C) Hyperthermia CA animals. (D) 
Representative SSEP recordings at 210min post-ROSC for each CA temperature group. 
The lighter grey lines are the multiple sweeps during the 15 min interval. The 
superimposed black line is the average of all the sweeps for the time period.  
 
2.3.2   SSEP Marker Changes from Baseline in Sham and CA Animals  
The sham animals had significantly higher N10 amplitudes (79% increase, p<0.05) and 
significantly longer N7 and N10 latencies (35%, 27% increases, respectively, p<0.01 for 
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both) under hypothermia compared to normothermia. Additionally, the sham animals had 
significantly shorter N7 and N10 latencies (8%, 7% decreases, respectively, p<0.05 for 
both) and similar N10 amplitudes (14% decrease, p>0.05) under hyperthermia compared 
to normothermia. One sham animal was excluded from the statistical analysis due to 
abnormal baseline waveforms. 
 
The hypothermic CA animals had significant increases in N7 and N10 latency (13%, 21% 
increases, respectively, p<0.01 for both) from pre-CA baseline and a non-significant 
decrease in N10 amplitude (22% decrease, p>0.05). The hyperthermic CA animals had 
significant decreases in N7 latency and N10 amplitude (19%, 71% decreases, 
respectively, p<0.01) and no change in N10 latency (0% change) compared to pre-CA 
baselines. The normothermic CA animals similarly had significant decreases in N7 
latency and N10 amplitude (8%, 78% decreases, respectively, p<0.01 for both) and a 
non-significant increase in N10 latency (3% increase, p>0.05).  The hyperthermia sham 
animals had significant decreases in N7 and N10 latency compared to normothermia, 
however the hyperthermia CA animals had a larger decrease in N7 latency and no change 
in N10 latency compared to pre-CA baseline values.  
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2.3.3   N10 Amplitude was Higher and had Better Recovery Over Time in 
Hypothermic CA Animals 
The comparison of normalized aggregate N10 amplitudes between temperature groups 
showed that hypothermic animals had significantly higher peaks than normothermic and 
hyperthermic animals over the first 4 hrs of recovery (p<0.01 for both) (Fig. 2.3A). In the 
time evolution of the N10 amplitude during recovery, hypothermic animals had 
significantly higher amplitudes than normothermic animals at all time points (p<0.05 at 
all time points) and than hyperthermic animals at all time points (p<0.05 at all time 
points) (Fig. 2.3B). The N10 amplitudes (aggregate and time evolution) are shown in 











Figure 2.3 (A) Aggregate N10 amplitude was significantly higher in hypothermic CA animals than normothermic and hyperthermic 
CA animals. (B) Time evolution of N10 amplitude by CA temperature group. The amplitude was significantly greater in hypothermic 
CA animals than both normothermic and hyperthermic CA animals at all time points. * p<0.05, ** p<0.01
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Table 2.2 Normalized N10 Amplitude (mean±S.E.M.) for temperature groups 
 Aggregate 30min 60min 90min 120min 150min 180min 210min 
Normothermia 0.173±0.022 0.150±0.044 0.093±0.034 0.095±0.024 0.166±0.053 0.228±0.062 0.224±0.056 0.262±0.097
Hypothermia 0.824±0.090 0.604±0.165 0.651±0.158 0.626±0.076 0.732±0.110 1.021±0.312 1.112±0.366 1.076±0.342
Hyperthermia 0.233±0.040 0.104±0.052 0.212±0.123 0.294±0.159 0.290±0.128 0.233±0.105 0.201±0.069 0.270±0.078
Significance ** ‡‡ * ‡‡ ** ‡ ** ‡ ** ‡‡ ** ‡‡ ** ‡‡ * ‡ 
* p<0.05, ** p<0.01 between normothermia and hypothermia 
† p<0.05, †† p<0.01 between normothermia and hyperthermia 




2.3.4   Animals with Good Outcome had Better Recovery of N10 Amplitude  
Following all CA experiments, animals were grouped based on their functional outcome, 
as defined by their 72hr NDS score. The animals with good outcome had a significantly 
higher aggregate N10 amplitude in the first 4 hrs post-ROSC compared to those with 
poor outcome (p<0.01) (Fig. 2.4A). While the time evolution of the N10 amplitude 
during recovery did not have significant differences between outcome groups, there is a 
clear trend showing that poor outcome animals mostly had decreasing N10 amplitude 








Figure 2.4 (A) Aggregate N10 amplitude was significantly higher in CA animals with good outcome compared to those with poor 
outcome. (B) CA animals with good outcome had increasing N10 amplitude over time while animals with poor outcome mostly had 
decreasing amplitude. * p<0.05, ** p<0.01 
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2.3.5   Predictive value of N10 amplitude  
Bivariate analyses were performed to determine the correlation between N10 amplitude 
and 72hr NDS score. The aggregate N10 amplitude correlated to the 72hr NDS (Pearson 
correlation coefficient: 0.231, p<0.01) (Table 2.3).  
 
The receiver operating characteristic (ROC) curve was used to determine the predictive 
value of good outcome of N10 amplitude. The predictive value was deemed good when 
the area under the ROC curve (AUC) was significantly different than the 0.5 reference 
curve, which indicates 50% accuracy. Since it is crucial in prognostication following CA 
to minimize incorrectly identifying a poor outcome patient as good, the cutoff point for 
these markers were determined at the point of 100% specificity for poor outcome and 
maximum sensitivity. In the prediction of good outcome, the N10 amplitude at 30min 
post-ROSC had a prediction accuracy of 79% (p<0.05) at which time point a normalized 
amplitude > 0.346 had 50% sensitivity and 100% specificity (Table 2.3).  
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Figure 2.5. ROC curve for the N10 amplitude at 30min after resuscitation has an 





Table 2.3 Predictive value of N10 amplitude 
 Aggregate 30m 60m 90m 120m 150m 180m 210m 
 Pearson correlation coefficients between SSEP markers and 72 hr NDS 
N10 Amplitude 0.231** 0.399 0.206 -0.034 0.093 0.264 0.338 0.313 
 Normalized latency cut-off points for good outcome (sensitivity, accuracy) with 100% specificity 






--a --a --a --a --a --a 
* p < 0.05, ** p < 0.01, a > 0.05 
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2.3.6   N7 Amplitude  
During the N7 amplitude analysis, the N7 peak was consistently concealed by the much 
larger N10 peak, particularly in the baseline measurements, before the N10 peak was 
suppressed due to the hypoxic injury. Thus, the N7 amplitude could not be reliably 
measured throughout the experiment. However, although the N7 amplitude could not be 
reliably measured, the location of the N7 peak was evident in most animals, thus, the N7 
latency could still be reliably measured (normothermia, n=4; hypothermia, n=5; 
hyperthermia, n=5).   
 
2.3.7   N7 and N10 Latency in Cardiac Arrest Animals  
Both N7 and N10 aggregate latencies were significantly longer in hypothermic animals 
than both normothermic and hyperthermic animals (p<0.01) (Fig. 2.6A-B). The aggregate 
N7 latency was also significantly different between normothermic and hyperthermic 
animals (p<0.01) such that latency increased with decreasing temperature (Fig. 2.6A). 
The time evolution of the N7 latency showed that the hypothermic animals had 
significantly longer values than both normothermic and hyperthermic animals at all time 
points (p<0.01) (Fig. 2.6C). The N7 latency was also significantly different between 
normothermic and hyperthermic animals at all time points after resuscitation except at 
60min (p<0.05) (Fig. 2.6C). The N10 latency was significantly longer in hypothermic 
animals than hyperthermic animals beginning at 60min after ROSC (p<0.05) (Fig. 2.6D) 
and than normothermic animals at all time points (p<0.01)(Fig. 2.6D). The aggregate and 
time evolution N7 and N10 latencies are shown in Tables 2.4 and 2.5, respectively.  
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Figure 2.6. (A) Aggregate N7 latency was significantly greater in hypothermic CA 
animals than normothermic CA animals, which was significantly greater than 
hyperthermic CA animals (B) Aggregate N10 latency was significantly greater in 
hypothermic CA animals than both normothermic animals and hyperthermic CA animals. 
(C) Normalized N7 latency was significantly higher in hypothermic CA animals than 
normothermic CA animals, which was significantly higher than hyperthermic CA animals 
at all time points except 60min. (D) Normalized N10 latency was significantly greater in 
hypothermic CA animals than normothermic CA animals at all time points and than 
hyperthermic CA animals from 60min until 4hr after ROSC. * p < 0.05, ** p < 0.01
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Table 2.4 Normalized N7 Latency (mean±S.E.M.) for temperature groups 
 Aggregate 30min 60min 90min 120min 150min 180min 210min 
Normothermia 0.937±0.012 0.917±0.026 0.929±0.037 0.932±0.040 0.943±0.034 0.947±0.046 0.932±0.034 0.962±0.017
Hypothermia 1.121±0.015 1.030±0.029 1.158±0.061 1.116±0.033 1.136±0.014 1.160±0.035 1.156±0.046 1.109±0.025
Hyperthermia 0.805±0.005 0.818±0.014 0.804±0.016 0.799±0.018 0.808±0.014 0.797±0.016 0.802±0.022 0.804±0.010
Significance ** †† ‡‡ ** ‡‡ ** † ‡‡ ** † ‡‡ ** † ‡‡ ** † ‡‡ ** † ‡‡ ** †† ‡‡ 
* p<0.05, ** p<0.01 between normothermia and hypothermia 
† p<0.05, †† p<0.01 between normothermia and hyperthermia 








Table 2.5 Normalized N10 Latency (mean±S.E.M.) for temperature groups 
 Aggregate 30min 60min 90min 120min 150min 180min 210min 
Normothermia 0.978±0.022 0.884±0.141 1.035±0.024 1.006±0.021 0.938±0.073 1.004±0.017 0.986±0.014 0.991±0.016
Hypothermia 1.209±0.012 1.155±0.023 1.235±0.048 1.204±0.029 1.205±0.019 1.235±0.033 1.238±0.038 1.196±0.024
Hyperthermia 0.941±0.013 1.032±0.065 0.920±0.034 0.930±0.031 0.923±0.026 0.940±0.029 0.937±0.031 0.924±0.023
Significance ** ‡‡ * **‡‡ ** ‡‡ ** ‡‡ ** ‡‡ ** ‡‡ ** †‡‡ 
* p<0.05, ** p<0.01 between normothermia and hypothermia 
† p<0.05, †† p<0.01 between normothermia and hyperthermia 
‡ p<0.05, ‡‡ p<0.01 between hypothermia and hyperthermia 
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The aggregate N7 and N10 latencies were both significantly longer in animals with good 
outcome compared to those with poor outcome (p<0.01 for both) (Fig. 2.7A-B). Similarly, 
the time evolution of latencies showed that N7 latency was significantly greater in good 
outcome animals compared to poor outcome animals at all time points in the early 
recovery period (p<0.01 for all time points) (Fig 2.7C). The N10 latency was 
significantly greater in animals with good outcome compared to animals with poor 








Figure 2.7. (A) Aggregate N7 latency was significantly greater in CA animals with good 
functional outcome than those with poor outcome. (B) Aggregate N10 latency was 
significantly greater in CA animals with good functional outcome than those with poor 
outcome. (C) Normalized N7 latency was significantly higher in good outcome CA 
animals than poor outcome CA animals at all time points. (D) Normalized N10 latency 
was significantly higher in good outcome CA animals than poor outcome CA animals 




2.4   Discussion 
In this study, we discovered that short-latency SSEP amplitude, specifically the N10 
amplitude, holds potential prognostic value following CA with TTM. The experiment 
demonstrated that normalized N10 amplitude during the early recovery is significantly 
greater in rats under hypothermia and in animals with good functional outcome following 
CA. Similarly, the peak analyses showed that larger N10 amplitudes are strongly 
associated with good functional outcome. Specifically, the aggregate N10 amplitude of 
the first 4 hours of recovery was significantly correlated with 72 hour NDS. We have 
shown for the first time that the N10 amplitude at 30min after ROSC, when all animals 
were still comatose, serves as an accurate predictor of good outcome at 72 hrs after 
ROSC. 
 
This study is among the first to demonstrate that SSEP signals recorded during the early 
recovery period under TTM can be quantified as objective measures to predict outcome 
following CA. This finding is significant as it not only validates the benefits of SSEP 
under TTM and during the early recovery period, but it also eliminates the subjective 
nature of current SSEP methods (determining whether N20 peaks are present or not), 
which has been shown to have only moderate interobserver reliability [141, 142]. 
 
The present study establishes the value of SSEP amplitudes in predicting good functional 
outcome during the early recovery after CA. The bilateral absence of N20 at 12-24 hrs 
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after resuscitation has been fairly well established as one of the most reliable predictors 
of poor outcome after CA in humans [133, 134, 136, 146]. However, the studies 
supporting this notion in most cases also emphasize that the presence of N20 does not 
predict that the patient will have good functional outcome. Thus, the present study is 
crucial as it identifies threshold values of existing peaks to identify subjects with good 
outcome. It is important to note that the N10 amplitude markers identified in this study 
are associated with predicting good outcome, whereas all established markers, namely the 
bilateral absence of the N20 peak, only reliably predict poor outcome. 
 
A recent prospective cohort study by Endisch et al. has demonstrated that SSEP 
amplitude holds prognostic value in post-CA patients treated with TTM [161]. The 
authors determined that bilaterally absent or very low amplitude (<0.62µV) short-latency 
cortical SSEPs had a sensitivity of 57% in the prediction of poor outcome while 
amplitudes above 2.5µV rule against severe hypoxic encephalopathy and have a 
sensitivity of 65% for good outcome. However, the recordings in this study all occurred 
after 24 hours post-ROSC, after TTM had been stopped, and therefore cannot be used to 
track recovery or for prognostication in the early recovery period. In the present study, 
we demonstrated that the rat N10 amplitude in the early recovery correlates with final 
outcome. We also found that normalized N10 values above 0.346 at 30min post-ROSC 
can predict good outcome with a sensitivity of 50% and with significant accuracy. This 
finding that higher amplitude is related to better outcome is consistent with a human 
study of normothermic post-CA patients, which found that patients with poor outcome 
54 
tended to have significantly lower N20 amplitudes compared to those with good outcome 
[160]. 
 
The N10 SSEP amplitude marker in the first 4 hours after CA was distinct among 
temperature and outcome groups and was associated with good functional recovery. 
Prognosis during the early recovery period following CA is crucial as it allows better 
titration of hypothermia and other treatments. Multiple groups have suggested waiting 24 
hrs before taking SSEP measurements in clinical settings, as some patients with absent 
SSEP peaks before 24 hrs eventually regained consciousness [144], or because SSEP 
signals tend to improve over the first 24 hrs [143]. However, in this rat study we have 
shown that the differences in early recovery are associated with good outcome, while 
temperature management is still in progress.  
 
All three temperature groups of CA animals had a decrease in N10 amplitude from their 
respective pre-CA baselines, which differs from the sham data, which showed that N10 
amplitude is increased by hypothermia and unchanged by hyperthermia, suggesting that 
CA leads to an additional decrease in N10 amplitude. This is a trend that was seen in 
multiple studies of SSEP during cardiac surgery with cardiopulmonary bypass, in which 
all studies saw a decrease in the cortical peak amplitude [156-159, 167, 168]. However, 
the effect of hypothermia on SSEP amplitude is not fully elucidated as various groups 
have observed increases, decreases, or no change in amplitude depending on the 
recording site and the condition of the subject [135, 151, 153, 154]. One study found that 
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hyperthermic temperatures have no significant effect on peak amplitudes in rats [154]. 
The cohort study by Endisch et al. found that temperature did not impact the relation 
between SSEP amplitude and outcome, when comparing SSEPs that were recorded above 
and below 35°C.  
 
Although SSEPs are less vulnerable to the effects of anesthetics than EEG, isofluorane 
has been shown to decrease the P40-N50 SSEP amplitude in humans [169]. In the present 
study, the isofluorane administered during the recovery period was minimal. Thus, we do 
not believe that this influenced the amplitude differences between groups. Moreover, in a 
clinical CA setting, anesthesia is generally not restarted during the very early recovery 
period. Further, the Endisch et al. study found that sedation did not largely impact the 
relationship between SSEP amplitude and functional outcome.  
 
The sham data compared to the CA data demonstrates the effect of CA on SSEP signals 
under temperature management. There were significant increases in both N7 and N10 
latencies with and without CA, however the percent increase in the latencies is smaller in 
the CA animals. The sham data corroborate previous studies that unanimously 
demonstrate that hypothermia increases SSEP latency [150-154, 156-159, 167, 168] and 
that hyperthermia decreases latency [154]. Thus, the SSEP peak latency appears to be 
confounded by temperature, which consequently impacts the prognostic value while the 
subject is under TTM. 
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Our study is limited in that it uses baseline SSEP measurements to normalize the post-CA 
recordings. It is unrealistic to expect baseline measurements for CA patients in a clinical 
setting, which is the application goal for these quantified SSEP markers. To address this, 
we expect that generalized baseline values could be generated from a standardized 
control group. Additionally, a larger study, perhaps with a more severe injury, is 
necessary to further elucidate the temperature effect on CA animals with SSEP. All 
hypothermia animals with moderate brain injury after 7min CA in the present study had 
good outcome, so the cutoff points generated may not account for the temperature effect 
of hypothermic animals with poor outcome after severe brain injury. Finally, while we 
were able to examine the relationship between SSEP characteristics and functional 
outcome, histological analyses were not performed in the present study to examine the 
relationship between SSEPs and cerebral injury level. However, a previous study used a 
rodent CA model to demonstrate that electrical stimulation of the median nerves during 
the early recovery period does not amplify the neurologic damage at 48 hrs post-ROSC 
[170]. The overall goal of this project is to develop quantitative markers that hold 
prognostic value during the early recovery period following CA that can be translated to 
clinical settings and to demonstrate feasibility.  
 
2.5   Conclusion  
The present study demonstrated that SSEP measurements are valid under TTM and may 
hold more prognostic value as quantitative markers than the dichotomous distinction of 
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present/absent peaks. Specifically, we were able to show that the rat N10 amplitude has a 
better recovery under hypothermia than normothermia or hyperthermia in the early 
recovery following CA and has prognostic value in the prediction of good outcome 
following CA with temperature management in a rat model. The ultimate goal of this 
study is to translate the quantitative markers to a clinical setting to improve 















CHAPTER 3: EVOLUTION OF QUANTIFIED 
SOMATOSENSORY EVOKED POTENTIALS AFTER 
CARDIAC ARREST WITH TARGETED TEMPERATURE 
MANAGEMENT  
3.1   Introduction  
Although the resuscitation and treatment protocols for cardiac arrest (CA) victims are 
being continuously improved, the functional outcome of survivors is still often poor. 
Among those patients who survive the cardiac event, morbidity and mortality are 
primarily caused by poor neurological recovery [31, 34, 171]. Targeted temperature 
management (TTM), specifically induced hypothermia of 32-34°C for 12-24 hours, is a 
recommended treatment in the guidelines provided by the American Heart Association 
(AHA) [49], and has been shown to improve survival and functional outcome [23, 41]. 
Early prognostication, ideally in the first few hours following resuscitation while the 
patient is still under TTM, could crucially impact the subsequent treatment and resource 
allocation, which ultimately could help to improve final functional outcome of post-CA 
patients.   
 
The challenges in monitoring and predicting cerebral recovery shortly after resuscitation 
from CA have been well documented [99, 100, 132, 154, 172]. Somatosensory evoked 
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potentials (SSEP) are used in post-CA patients to assess the recovery of evoked neural 
activity. Thus, evaluation of SSEP, such as changes in waveform amplitude, latency, or 
shape, while the CA patient is comatose following resuscitation could help assess the 
cerebral damage and potential recovery.  
 
The prognostic value of SSEP, even under TTM, has been well verified, as the bilateral 
absence of the N20 SSEP peak is currently the best prognostic indicator of poor 
functional outcome [42, 88, 129-136]. However, not only is this method highly subjective, 
even among highly trained experts [141, 142], it is also temporally limited, as it is has 
been suggested to be most reliable at least 12-24 hours after resuscitation [42], at which 
point much of the ischemic damage by CA has already begun. The current SSEP signal 
interpretation requires highly experienced personnel and since CA survivors are often 
monitored by physicians and nurses with little experience in neurological examination, 
the implementation of this method is complicated. Further, the small changes in cerebral 
recovery that may have a more substantial impact on functional outcome may not be 
accounted for with the dichotomous categorization of SSEP peak presence. An early 
quantitative SSEP marker would simplify the analysis, remove the subjectivity of the 
interpretation, and account for varying levels of injury, which could allow for earlier 
prognostication and better assist treatment. Thus, a quantitative SSEP measurement 
would address the limitations of the current gold-standard method, allowing for earlier 
and objective prognostication.  
60 
Our recently developed quantitative SSEP (qSSEP) metric that objectively captures the 
morphologic information of the SSEP waveform, represented by a single numeric value 
termed the qSSEP phase space area (qSSEP-PSA), was previously shown to hold 
predictive value for functional outcome following CA during the early recovery period in 
rats [145]. Here, for the first time, we test the robustness of the qSSEP-PSA metric in 
tracking cerebral recovery following CA under three temperature conditions: 
hyperthermia, normothermia and hypothermia.  
 
3.2   Materials and Methods  
3.2.1   Animals  
In these experiments, we recorded the SSEPs in a rodent CA model with temperature 
management. Twenty-one animals underwent 7min asphyxia-CA and resuscitation 
followed by immediate temperature management of one of three temperatures: 
hypothermia, normothermia, or hyperthermia (n=7/group), which was randomly assigned 
prior to CA. An additional 14 sham operation rats underwent the same experimental 
procedures except for CA and resuscitation. All experiments were approved by the 
Institutional Animal Care and Use Committee at Johns Hopkins University.  
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3.2.2   Animal Preparation  
All animals had 5 screw electrodes (Plastics One, Roanoke, VA) implanted in the skull to 
record the SSEPs [145, 162] from the somatosensory cortex. Once implanted, the screws 
were secured with a plastic pedestal and dental cement. The animals were then returned 
to their home cage and allowed 1 week of recover before the CA experiment.  
 
3.2.3   Cardiac Arrest, Resuscitation and Temperature Management 
The CA and resuscitation procedures were performed as previously described [46, 110, 
113, 145]. On the day of CA, rats were mechanically ventilated and anesthetized with 
1.5% isofluorane in 1:1 O2:N2 following intubation. The femoral artery and vein were 
cannulated to measure arterial blood gases (ABG) and to administer drugs. A baseline 
SSEP measurement was recorded for 15 min followed by a 5 min anesthetic washout 
period, during which vecuronium (2mg/kg) was administered. Asphyxial CA was 
induced as previously described, lasting for 7min. Resuscitation was performed by 
administering cardiopulmonary resuscitation (CPR) along with epinephrine and sodium 
bicarbonate until the return of spontaneous circulation (ROSC).  
 
SSEP recordings resumed 30 min after ROSC and were continued in 15 min intervals 
until 4 hours after ROSC. Isofluorane was delivered as needed, not exceeding 0.5%, 
during SSEP recordings in the recovery period as the nerve stimulation may cause 
discomfort to the rats [154, 162]. 
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Temperature was measured rectally and was recorded every 10 min. Temperature 
management began immediately after ROSC was achieved. The hypothermia group was 
cooled to 32-34°C within 15 min, which was maintained for 4 hours followed by 
rewarming to normothermia (36.5-37.5°C) over a period of 2 hours. The hyperthermia 
animals were warmed to 38.5-39.5°C within 15 min, which was maintained for 4 hours 
followed by passive cooling to normothermia over a period of 2 hours. Normothermia 
animals were maintained at 36.5-37.5°C for 4 hours after ROSC using a heating pad. 
After temperature management, all animals were then placed in a neonatal incubator at 
28°C to maintain normothermia (36.5-37.5°C) until 24 hours after ROSC.  
  
3.2.4   Functional Outcome  
The neurologic recovery of the rats was determined using the Neurologic Deficit Scale 
(NDS). Animals were evaluated by a trained and blinded assistant at 6, 24, 48 and 72 hrs 
after ROSC. A 72hr NDS score greater than 60 was designated as good functional 
outcome, while less than 60 was determined to be poor outcome [46].  
	
3.2.5   SSEP Measurement  
SSEP signals were recorded from the cortical screw electrodes while stimulating 
(200µsec, 6mA 0.5Hz) the median nerve in each forelimb of the rat with subdermal 
needle electrodes. SSEPs were acquired by the TDT System3 data acquisition system 
(Tucker-Davis Technologies, Alachua, FL) at a frequency of 6.1kHz. SSEP 
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measurements were taken for 15min prior to CA (baseline) and beginning at 30min after 
ROSC, continuing in 15 min intervals until 4 hr post-ROSC.   
 
3.2.6   qSSEP-PSA Calculation   
The qSSEP-PSA metric calculation is explained in detail by the developing authors [145]. 
Briefly, the SSEP waveforms within each 15 min interval (450 sweeps) were averaged. 
Then, the phase space curve (PSC) was generated for each time interval by plotting the 
first derivative against the magnitude. The PSC represents the morphologic information 
of the waveforms. The area bound by the PSC was then calculated, which is referred to as 
the qSSEP phase space area (qSSEP-PSA) and represents the power of the SSEP signal. 
Specifically, the area of the PSC is determined by the Quickhull algorithm, which fits a 
convex hull to the PSC [173]. The convex hull is determined using the point-index based 
method, which identifies the PSC indices that lie along the boundary of the convex hull. 
The qSSEP-PSA is the area within this boundary. Thus, the algorithm captures extensive 
information of the waveform shape, providing a more encompassing representation of the 
SSEP than merely amplitude or latency. A custom MATLAB (MathWorks, Natick, MA) 
algorithm was used for all computations. 
 
Once the qSSEP-PSA was calculated for each 15 min interval, the values were 
normalized to the baseline qSSEP-PSA. The aggregate qSSEP-PSA considers the 
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normalized value of all 15 min time periods. Waveforms with abnormal baselines 
(bilaterally distorted N10 and P15 peaks) were excluded from the analysis [162].  
  
3.2.7   Statistics  
The commercial SPSS statistics computer package (IBM SPSS Statistics v22, Armonk, 
NY) was used for all statistical analyses. The 72 hour NDS score, reported as the [median 
(25th, 75th percentiles)] was compared between temperature groups using a nonparametric 
Kruskal-Wallis test. The qSSEP-PSA metric was compared between temperature groups 
using a repeated measures analysis of variance (ANOVA) and between outcome groups 
using a one tailed student’s t-test, assuming unequal variances. The correlation between 
qSSEP-PSA and 72 hr NDS was determined using a bivariate analysis to obtain the 
Pearson correlation coefficients. A p value less than 0.05 was considered statistically 
significant.  
 
3.3   Results  
3.3.1   Baseline Data, Temperature Monitoring, and NDS 
The core temperature of all animals was closely monitored and maintained at their 
designated temperature (normothermia: 36.9±0.10°C, hypothermia: 32.8±0.10°C, 
hyperthermia: 38.9±0.03°C). The target temperatures were reached within 15mins 
following ROSC (Fig. 3.1). The baseline weight and ABG data prior to CA were not 
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significantly different between temperature groups (p>0.05, data not shown). The 
hypothermia animals had the highest 72 hr NDS score [74 (74,77)] compared to the other 
temperature groups (p<0.01). The normothermia animals also had significantly higher 72 
hr NDS scores [68 (49,72)] compared to hyperthermia animals [0 (0, 58)] (p<0.01). 
Using a 72 hr NDS score of 60 as the cutoff, there were 9 animals with poor outcome 




Figure 3.1 Temperature was well monitored throughout the experiment. Temperature management occurred between the dashed lines, 
beginning at ROSC (time 0 min) and ending at 4 hours post-ROSC (time 240min).  
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3.3.2   Sham Animal Data  
For the sham animals, the percent change in qSSEP-PSA from a normothermia baseline 
was determined under hypothermia and hyperthermia (Table 3.1). The sham animals had 
a 37% increase (p>0.05) in qSSEP-PSA under hypothermia and a 32% decrease (p>0.05) 
under hyperthermia, compared to normothermia.  
 
3.3.3   Change in qSSEP-PSA from Baseline Following CA 
The CA animals of all three temperature groups had a decrease in qSSEP-PSA compared 
to the pre-CA baseline (Table 3.1). The normothermia CA animals had the largest percent 
decrease (89%, p<0.01), while the hypothermia CA animals had the smallest percent 
decrease (31%, p>0.05). Hyperthermia resulted in a decrease in qSSEP-PSA in sham 
animals (p>0.05), however, the decrease was even larger and significant in hyperthermia 
CA animals (p<0.05). Hypothermia resulted in a decrease in CA animals, though the 







Table 3.1 Percent changes in qSSEP-PSA in sham and CA animals  
Temperature Intervention PSA 
Hypothermia Sham +37% 
CA -31%  
Hyperthermia Sham -32% 
CA -59% * 
Normothermia Sham -- 
CA -89% ** 
* p <0.05, ** p < 0.01 compared to pre-CA baseline 
 
3.3.4   Recovery of qSSEP-PSA Following Cardiac Arrest  
SSEP recordings were obtained for each animal and followed a general trend of 
decreased SSEP peak amplitude (qualitative) during the recovery period compared to 
baseline. In general, the hypothermia animals had the best recovery of SSEP peaks to 
baseline size and shape while hyperthermia animals tended to have the worst recovery, 
resulting in smaller size peaks with abnormal shape (Fig. 3.2A). The corresponding PSCs 




Figure 3.2 Representative SSEP waveforms for (A) normothermia, (B) hypothermia, and 
(C) hyperthermia animals throughout the experimental period. The lower panels display 
the corresponding phase space curves for (D) normothermia, (E) hypothermia, and (F) 
hyperthermia animals. 
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3.3.5   Aggregate qSSEP-PSA is Higher in Hypothermic Animals   
The aggregate qSSEP-PSA was calculated for each temperature group by considering all 
the normalized qSSEP-PSA values over the 4 hour early recovery period following 
ROSC. The aggregate qSSEP-PSA was significantly higher in the hypothermia group 
than both the hyperthermia group (p<0.05) and the normothermia group (p<0.01) (Fig 
5.3). The aggregate qSSEP-PSA was also significantly greater in the hyperthermia group 
compared to the normothermia group (p<0.05) (Fig. 5.3).   
 
 
Figure 3.3. Aggregate normalized qSSEP-PSA was significantly larger in hypothermia 
animals compared to both normothermia and hyperthermia animals. * p<0.05, ** 
p<0.01. 
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3.3.6   qSSEP-PSA Increases More in Hypothermic Animals During Early Recovery  
The comparison of the time evolution of the normalized qSSEP-PSA values between 
temperature groups showed that hypothermia values tended to increase throughout the 
early recovery period (Fig. 5.4). Normothermia qSSEP-PSA values tended to increase 
slightly but stayed relatively the same over time (Fig. 5.4). The hyperthermia animals 
showed a slight increase in qSSEP-PSA values during the early stages of recovery (30-
90min) followed by a decrease in values during the remainder of the early recovery 
period. The hyperthermia animals had a significantly higher qSSEP-PSA than 
normothermic animals at 60 and 90min post-ROSC (p<0.05) (Fig. 5.4). One animal in the 
hypothermic group had an SSEP peak that was much larger in the recovery period than at 
baseline, which is unusual for animals that have undergone ischemic injury due to CA, 
however, the baseline data for this animal was normal. This phenomenon caused a very 
large S.E.M. value in the hypothermic animals. The aggregate and time evolution qSSEP-




Figure 3.4. Time evolution of normalized qSSEP-PSA between temperature groups. 
qSSEP-PSA in hypothermia animals trended upwards over time while qSSEP-PSA in 
hyperthermia animals increased slightly then decreased further into the recovery period. 
* p < 0.05.
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Table 3.2 Normalized qSSEP-PSA (mean±S.E.M.) for temperature groups 
 Aggregate 30min 60min 90min 120min 150min 180min 210min 
Normothermia 0.109±0.015 0.088±0.021 0.073±0.025 0.068±0.023 0.112±0.039 0.142±0.047 0.130±0.046 0.148±0.071
Hypothermia 0.697±0.155 0.412±0.189 0.332±0.081 0.379±0.064 0.482±0.137 0.821±0.368 0.965±0.475 1.616±0.967
Hyperthermia 0.406±0.065 0.261±0.080 0.443±0.181 0.604±0.294 0.481±0.199 0.392±0.175 0.295±0.095 0.345±0.098
Significance ** † ‡  † †     
* p<0.05, ** p<0.01 between normothermia and hypothermia 
† p<0.05, †† p<0.01 between normothermia and hyperthermia 







3.3.7   Animals with Good Functional Outcome Have Better Early qSSEP-PSA 
Recovery  
The aggregate qSSEP-PSA of the first 4 hrs post-ROSC for animals with good functional 
outcome (72hr NDS ≥ 60) was higher than that of animals with poor functional outcome 
(72hr NDS < 60) (Fig. 3.5A), though the difference was not significant with the current 
animal cohort (p>0.05). The time evolution of the qSSEP-PSA shows that animals with 
good functional outcome had increasing qSSEP-PSA over the first 4 hours post ROSC 
(Fig. 3.5B). Conversely, the animals with poor functional outcome had increasing 
qSSEP-PSA values from 30-90 min post-ROSC followed by decreasing values for the 
remainder of the early recovery period (Fig. 3.5B). Overall, there was better recovery of 
the qSSEP-PSA metric in animals with good functional outcome compared to those with 
poor functional outcome.  
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Figure 3.5. A) Animals with good functional outcome had higher aggregate qSSEP-PSA 
than animals with poor outcome. B) Animals with good functional outcome had better 




3.3.8   Predictive and Tracking Values of qSSEP-PSA with Temperature 
Management  
The qSSEP-PSA was correlated with 72hr NDS at 60 and 90 min post-ROSC (Pearson 
correlation coefficients: -0.528, -0.543, respectively, p<0.05) (Table 3.3). Receiver 
operating characteristic (ROC) curves were generated for the prediction of good outcome 
using the qSSEP-PSA metric for both aggregate and time evolution values. The AUC was 
not significantly different from the 0.5 reference for the aggregate qSSEP-PSA and the 
qSSEP-PSA at each time point during the early recovery (p>0.05). The accuracy of the 
metric is deemed good when the area under the ROC curve (AUC) is significantly 
different (p<0.05) from the standard of 0.5, indicating that it is a good predictor of good 
functional outcome. 
 
Table 3.3 Pearson correlation coefficients for qSSEP-PSA and 72 hour NDS score 




















* p < 0.05 
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3.4   Discussion  
In this study, we applied the recently developed qSSEP-PSA algorithm to SSEP signals 
of post-CA rats treated with TTM, and determined that the quantitative marker shows 
distinct trends among both temperature groups and functional outcome groups over the 
early recovery period. We have demonstrated that the qSSEP-PSA marker holds the 
potential to objectively track early recovery on a wide scale to account for multiple 
recovery statuses. More specifically, this marker provides a potential improvement on the 
current SSEP standard of present/absent dichotomous classification, as it provides a 
continuous scale of possible values that may represent various levels of recovery or 
injury, which is both objective and available during the early recovery period. We have 
shown that there are distinct trends of the qSSEP-PSA marker within the first 4 hours of 
recovery, importantly suggesting that early SSEP tracking and prognostication may be 
valid and beneficial. Furthermore, the qSSEP-PSA marker provides an objective 
measurement that does not require sophisticated training to interpret, in contrast to the 
current SSEP method of classification.  
 
Our results show that there are significant differences in aggregate qSSEP-PSA between 
all three temperature groups during the early recovery such that hypothermia animals had 
significantly larger qSSEP-PSAs than the other temperature groups. Although the 
hypothermia and hyperthermia groups had similar recovery in the first 120min after 
ROSC, the hypothermia animals had distinctly better improvement, particularly from 
150-240min after resuscitation. A similar observation was seen in the burst frequency in 
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post-CA rats, where both hypothermic and hyperthermic treated animals had increased 
bursting during the early recovery [166]. This observation supports the notion that the 
evolution of SSEP can track the improved recovery that is expected of hypothermia 
treated subjects. The sham data demonstrates that the distinct evolution among 
temperature groups is a result of the varying levels of injury, as hypothermia and 
hyperthermia caused nonsignificant increases and decreases from baseline, respectively, 
in sham animals.  
 
The recovery of qSSEP-PSA between functional outcome groups was similar to that 
among temperature groups for the first half of the recovery period (i.e. not much 
distinction between groups), however, from 150-240min post-ROSC, the animals with 
good functional outcome distinctly trended upwards while the poor outcome animals had 
decreasing qSSEP-PSA. This corroborates a previous study that demonstrated that SSEPs 
evolve at different rates depending on the injury level [162].  
 
Although the N20 absent/present assessment has been proven to be robust in predicting 
poor outcome, it is still limited by the dichotomous standard, as the method does not have 
the ability to guide treatment. While the method has repeatedly shown a specificity of 
100% for poor outcome, the sensitivity is often low, around 45% [94, 144]. The low 
sensitivity is most often due to a small proportion of patients that end up with poor 
outcome actually having bilaterally absent N20s [174]. Additionally, the presence of N20 
peaks does not indicate good outcome – almost half of patients with present N20s will 
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have poor outcome [175]. Therefore, it is important to consider the entire waveform 
morphology and create a continuous quantitative SSEP marker to track the recovery. As 
each of the SSEP peaks originate from varying brain structures, it is reasonable that a 
holistic quantification of the SSEP waveform may help maximize prognostic value. We 
have demonstrated here that the qSSEP-PSA marker achieves quantification of the entire 
SSEP waveform. Quantitative SSEP markers allow for prognostication during the early 
recovery period when peaks tend to have very low amplitudes but may have the potential 
to increase over time. These low amplitude peaks would likely be categorized as absent 
using the existing classification method, but a quantitative marker provides a continuous 
scale to assess the various levels of recovery. The qSSEP-PSA provides this continuous 
scale that eliminates the need for an abnormal observation (i.e. absent N20s) to be useful 
in prognostication.  
 
The current method of identifying absent N20 peaks is subjective and requires 
sophisticated training. One study examined the interobserver variability in the 
classification of N20 peaks and showed that the interobserver agreement between 5 
experts was only moderate [142]. Further, there is a possibility of misclassification when 
distinguishing between an absent peak and a highly attenuated peak, as is often the case 
during the early recovery period. The qSSEP-PSA marker presented here is an objective 
and quantitative representation of the SSEP signal, and therefore completely eliminates 
the subjective interpretation of SSEP waveforms, addressing a major limitation of the 
standard N20 absent/present method.  
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It has been suggested that SSEPs should not be measured before 24 hours, as they may be 
unreliable [137], and the American Academy of Neurology (AAN) recommendation 
states that the N20 bilateral absence on days 1-3 after CA should be used to assess poor 
prognosis [176]. However, it has also been documented that TTM has the greatest 
protective benefits when applied immediately after resuscitation [71]. This may be 
explained in part by the damaging molecular cascades that occur during hypoxia and 
reperfusion [4], resulting in the ischemic injury experienced in CA patients. Thus, early 
tracking and prognostication is important to help guide treatment and management during 
the period of secondary injury. Our study demonstrates that the qSSEP-PSA metric is 
valid during the early recovery, which is an important improvement on the dichotomous 
N20 classification that requires physicians to wait 24 hours before the method is useful. 
 
One limitation of our study is that it uses pre-CA baseline qSSEP-PSA values for 
normalization, which is not practical in clinical applications. This could be solved by 
generating standardized baseline values using typical representative waveforms. 
Additionally, the study is limited by the outcome distribution within temperature groups, 
specifically, the hypothermia group. In the present study, all hypothermia animals had 
good outcome, which is not representative of clinical outcomes. It may be necessary to 
induce a more severe injury so that the performance of the qSSEP-PSA marker can be 
further evaluated with temperature management.        
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3.5   Conclusion  
We have demonstrated that the qSSEP-PSA marker evolves differently among 
temperature and functional outcome groups in post-CA rats. Hypothermic animals and 
animals with good functional outcome had better qSSEP-PSA recovery during the early 
recovery period. This quantitative marker provides many benefits over the current 
standard of N20 absence/presence distinction. Specifically, we presented a marker that 
objectively quantifies SSEPs on a continuous scale, which may hold potential prognostic 
value. Ultimately, the goal of this study is to generate quantitative markers that can be 









CHAPTER 4: QUANTITATIVE ANALYSES OF 
SOMATOSENSORY EVOKED POTENTIALS AFTER 
CARDIAC ARREST WITH GRADED HYPOTHERMIA  
4.1   Introduction  
Targeted temperature management (TTM), hypothermia of 32-34C, has been shown to 
improve survival and neurological outcome following CA [23, 41]. However, it has not 
been clearly demonstrated which level of hypothermia is most beneficial to outcome. 
Multiple grades of hypothermia have been studied in both humans and animals [23, 41, 
73, 80], but it is unclear which provides the best neuroprotection following CA.  
 
Reliable prognostication during the early recovery period following CA would positively 
impact the subsequent treatment. While multiple prognostic tools exist, their reliability 
under hypothermia has been questioned [42, 88, 132, 177, 178]. However, it has been 
suggested that somatosensory evoked potentials (SSEP) maintain prognostic value under 
TTM [50].  
 
Although SSEP have proven to be a useful prognostic tool for comatose patients in post-
CA recovery [133, 134], the major need for a reliable and objective prognostic tool to 
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track recovery has been established. In this preliminary study, we describe multiple 
quantitative analyses of SSEP – N10 amplitude and latency and quantitative SSEP phase 
space area (qSSEP-PSA) – with the potential to track early cerebral recovery following 
severe brain injury in a 9 min CA rat model with graded hypothermia. We tested the 
potential prognostic value of these markers under graded hypothermia and discovered 
that SSEPs hold prognostic value in the form of graded quantitative markers that extend 
beyond the dichotomous categorization of peaks. 
 
4.2   Materials and Methods  
4.2.1   Animals  
In this preliminary study, a total of 16 adult male Wistar rats (371±12 g) underwent 9 min 
asphyxial CA. The animals were randomly assigned to normothermia or one of three 
grades of hypothermia (n=4/group): N0 (36.5-37.5C), H1 (30-32C), H2 (32-34C), H3 
(34-36C). All procedures were approved by the University of Maryland Animal Care 
and Use Committee.  
 
4.2.2   Cardiac Arrest and Temperature Management  
The asphyxia-CA and resuscitation were performed as previously described [46, 110, 113, 
145, 166]. Rats were intubated and continuously anesthetized with 1.5% isofluorane in 
1:1 O2:N2, delivered by a mechanical ventilator. The femoral vein and artery were 
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cannulated and 15 min baseline SSEPs were recorded followed by a 5 min anesthetic 
washout period, during which Vecuronium (2 mg/kg) was administered. Following the 
washout, asphyxia was initiated. After 9 min of CA (MAP < 10 mmHg), 
cardiopulmonary resuscitation (CPR) was performed using sternal chest compressions, 
100% oxygen, epinephrine and sodium bicarbonate until return of spontaneous 
circulation (ROSC, MAP > 60 mmHg). SSEP recordings were taken in 15 min intervals 
from 30 min until 4 hrs after ROSC. Isofluorane was administered as needed (up to 0.5%) 
once SSEP recordings began during the recovery period due to the potential discomfort 
of the stimulations. 
 
Temperature management began immediately after ROSC was achieved. The 
hypothermic animals were immediately surface cooled and were maintained at their 
appropriate degree of hypothermia (H1 30-32C, H2 32-34C, H3 34-36C) for 6 hours 
after ROSC after which the animals underwent rewarming to normothermia (36.5-
37.5C) over 2 hours. The normothermia animals were maintained at 36.5-37.5C for 6 
hours after ROSC using a heating pad. A rectal probe was used to measure temperature, 
which was closely monitored and recorded every 5min. 
  
4.2.3   SSEP Acquisition and Analysis  
Approximately 3 days before the date of CA, rats had 4 screw electrodes (Plastics One, 
Roanoke, VA) cortically implanted over the somatosensory cortex with 1 ground 
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electrode over the parasaggital right frontal lobe. The screws were held in place with a 
plastic pedestal and dental cement [145, 162]. The SSEP signals were recorded from the 
skull electrodes following stimulation of the median nerves. Stimulation pulses (200usec, 
6mA) were delivered to subdermal electrodes at a frequency of 0.5Hz. The subsequent 
SSEPs were recorded with the TDT System3 data acquisition system (Tucker-Davis 
Technologies, Alachua, FL) at a frequency of 6.1kHz.  
 
The SSEPs were recorded for 15 min prior to CA (baseline) and beginning 30 min after 
ROSC, continuing in 15 min intervals until 4 hrs after ROSC. The sweeps within each 15 
min interval were averaged (450 sweeps) and the quantitative analyses were performed 
on the averaged waveform for each time period and then normalized to baseline values. 
The normalized values for each time period were then averaged to generate the aggregate 
value for each quantitative marker. Animals with abnormal baseline waveforms 
(bilaterally distorted N10 and P15) were excluded from the analysis. 
 
N10 amplitude and latency 
The rat N10 peak is equivalent to the N20 peak in humans. The N10 amplitude was 
measured as the peak-to-peak amplitude between the N10 and P15 peaks. The N10 
latency was measured as the time from stimulation to the N10 peak. The amplitude and 




The qSSEP-PSA marker was calculated as previously described [145]. Briefly, the phase 
space curve (PSC) of an SSEP waveform was generated by plotting the first derivative 
against the magnitude, thus capturing the morphologic information of the peak. The 
phase space area (PSA), a representation of the signal power, was calculated by 
determining the area bound by the PSC. The qSSEP-PSA was determined by fitting a 
convex hull to the PSC using the Quickhull algorithm [179]. The point-index based 
convex hull was calculated by identifying the indices of the PSC that exist along the 
boundary of the convex hull and the qSSEP-PSA is the area encompassed by this 
boundary. The algorithm selects points within the waveform, including transitional slopes 
and smaller peaks, as to capture the extent of the signal, therefore encompassing more 
information than merely an amplitude or latency. These analyses were performed using 
MATLAB [145]. 
  
4.2.4   Neurologic Recovery and Assessment  
The neurologic recovery of rats was assessed using the neurologic deficit scale (NDS) at 
6, 24, 28 and 72 hrs after ROSC. The 72 hr NDS was used to determine the final 
functional outcome such that good functional outcome was defined as 72 hr NDS ≥ 60 
and poor functional outcome as 72 hr NDS < 60 [46].  
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4.2.5   Statistics  
All statistical analyses were performed using a commercial computer package (IBM 
SPSS Statistics v22, Armonk, NY). The N10 amplitude and latency, and qSSEP-PSA 
(meanS.E.M.) were compared between temperature groups using a repeated measure of 
analysis of variance (ANOVA) and compared between outcome groups using a student’s 
t-test. Bivariate analyses were used to generate the pearson correlation coefficients 
between 72 hr NDS and quantitative markers. A p value < 0.05 was considered 
statistically significant.   
 
4.3   Results  
4.3.1   Temperature, NDS, Baseline Data  
The temperature was well monitored throughout the duration of the experiment. The 
groups were maintained at their respective temperature ranges: H1 (31.3±0.06C), H2 
(33.0±0.05C), H3 (34.7±0.04C), N0 (37.1±0.03C). Target temperatures were reached 
within 11±2min (H1: 18±3min; H2: 10±2min; H3: 5±0min). The 72 hr NDS (median 
(25th, 75th)) of each temperature group was as follows: H1 (58 (0, 68)), H2 (59 (14, 70)), 
H3 (39 (0, 77)), N0 (22 (0, 61)). Based on the 72 hr NDS, 7 animals had poor outcome (0 
(0,0)) and 9 animals had good outcome (66 (57,71)) (p<0.01). The baseline rat body 
weight was not significantly different among temperature groups (p>0.05, data not 
shown). 	
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4.3.2   N10 Amplitude   
The N10 amplitude of the early recovery period (first 4 hours after ROSC) showed a 
decreasing trend among increasing temperature groups (Fig. 4.1A). All three hypothermia 
groups (H1, H2 and H3) had significantly larger N10 amplitudes than the normothermia 
(N0) group (all p<0.05). The H1 group also had significantly larger N10 amplitudes than 
the H3 group (p<0.01). Animals with good outcome also had better N10 amplitude 
recovery compared to those with poor outcome, though the difference is not significant 
with the current animal cohort (p>0.05) (Fig. 4.1B).    
 
Figure 4.1 A) Normalized aggregate N10 amplitude among four temperature groups. All 
three hypothermia groups (H1, H2, H3) had significantly larger N10 amplitudes than N0. 
H1 also had significantly larger amplitude than H3. B) Normalized aggregate N10 
amplitude was higher in animals with good functional outcome. * p < 0.05, ** p < 0.01 
compared to N0. †† p < 0.01 compared to H3. 
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4.3.3   N10 Latency  
The early recovery N10 latency showed a decreasing trend among increasing temperature 
groups (Fig. 4.2A). All hypothermia groups (H1, H2, and H3) had significantly longer 
N10 latencies than the normothermia group (N0) (all p<0.01). The H1 and H2 groups also 
had significantly longer latencies than the H3 group (p<0.01) and the H1 group had 
significantly longer latencies than the H2 group (p<0.01). The N10 latency was very 
similar between animals with good outcome and those with poor outcome (p>0.05) (Fig 







Figure 4.2 A) Normalized aggregate N10 latency among four temperature groups. All 
three hypothermia groups (H1, H2, H3) had significantly longer N10 latencies than N0. 
H1 also had significantly longer latency than H2 and H3 while H2 had significantly 
longer latency than H3. B) Normalized N10 latency similar between the outcome groups. 
** p < 0.01 compared to N0. †† p < 0.01 compared to H3. ‡‡ p < 0.01 compared to H2.  
 
4.3.4   qSSEP-PSA  
The qSSEP-PSA during the early recovery was significantly larger in the H1 and H2 
groups than the N0 group (p<0.01) (Fig. 4.3A). The H3 qSSEP-PSA was also lower than 
the H1 and H2 groups and larger than N0, though the differences were not significant 
(p>0.05). qSSEP-PSA was also higher in animals with good outcome compared to those 
with poor outcome, although the difference was not significant (p>0.05) (Fig. 4.3B).  
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Figure 4.3 A) Normalized aggregate qSSEP-PSA among four temperature groups. Both 
H1 and H2 had significantly larger qSSEP-PSA values than N0. B) qSSEP-PSA was 
higher in animals with good outcome. ** p < 0.01 compared to N0.  
 
4.3.5   Correlation Between Quantitative Markers  
Among the quantitative markers, the N10 amplitude was significantly correlated with both 
N10 latency (pearson correlation coefficient: 0.400, p<0.01) (Fig. 4.4A) and qSSEP-PSA 
(pearson correlation coefficient: 0.904, p<0.01) (Fig. 4.4B).   
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Figure 4.4 N10 amplitude was significantly correlated to a) N10 latency and B) qSEEP-
PSA.  
 
4.4   Discussion  
In this study, the integrity of the somatosensory pathway following severe brain injury by 
asphyxial-CA was examined using multiple quantitative markers under graded 
hypothermic conditions, for the first time. We discovered that quantified SSEPs hold 
great potential to track recovery following CA with TTM by providing continuous 
quantitative criteria, thereby accounting for multiple conditions as opposed to 
dichotomous categorization. All three markers, N10 amplitude and latency, and qSSEP-
PSA, demonstrated clear trends among both temperature and functional outcome groups. 
This experiment demonstrates the potential prognostic value of these objective and novel 
quantitative markers for the early recovery after severe CA with graded TTM.  
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The majority of studies evaluating the prognostic value of SSEP following CA are focused 
on the bilateral absence of N20 [42, 88, 129-136] rather than the relationship between 
quantitative SSEP measures and outcomes. Only one human study has examined the 
relationship between SSEP amplitude and outcome, suggesting a threshold amplitude 
voltage to distinguish bad outcomes [161]. However, the study does not use specific 
response peaks in the evaluation of amplitude. Here we provide three quantitative, 
objective and repeatable SSEP markers that hold potential prognostic value following CA 
with temperature management.  
  
Our previous work developed the qSSEP-PSA marker and demonstrated the potential 
prognostic value of both qSSEP-PSA and N10 amplitude in normothermic animals with 
moderate and severe brain injuries following CA [145]. This study showed that animals 
with moderate injury had better PSA recovery than those with severe injury. Here we 
demonstrated that qSSEP-PSA had better recovery with deeper hypothermia (H1 and H2) 
compared to normothermia and in animals with good outcome compared to poor outcome. 
The qSSEP-PSA marker also mirrored the median 72 hr NDS among temperature groups 
(H2 > H1 > H3 > N0). The PSA marker is a strong measure of SSEP waveforms as it 
considerers multiple features of the entire signal rather than a single response peak 
characteristic.  
  
The N10 amplitude and latency have been previously studied in both moderate and severe 
brain injury (7 and 9 min CA, respectively) under normothermic conditions [162]. This 
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study demonstrated that amplitude recovery is better after moderate injury rather than 
severe injury and that latency decreases towards baseline over the early recovery period at 
both injury severity levels. The present study demonstrated better recovery of N10 
amplitude in animals treated with lower temperature grades and with good functional 
outcome and that N10 latency was overall longer than baseline in animals with deeper 
hypothermia. Although it has been demonstrated that hypothermia increases N10 
amplitude and N10 latency compared to normothermic groups in an uninjured rat model 
[154], it has been suggested that the effect of mild hypothermia (33C) does not have a 
significant effect on the relationship between SSEP amplitude and outcome in a human 
study [161].  
  
SSEP amplitude has been shown to be related to functional outcome [161]. Here we 
demonstrate that N10 amplitude is correlated with both N10 latency and PSA during the 
early recovery from severe brain injury with graded hypothermia. Thus, the prognostic 
potential of these quantitative SSEP markers, N10 amplitude, N10 latency, and qSSEP-
PSA, is further demonstrated.   
 
Although clear trends of the quantitative SSEP markers were demonstrated in this study, 
the results must be interpreted with caution, as this is a preliminary study with small 
animal numbers. The use of 72 hr NDS among temperature groups to evaluate the effect 
of graded hypothermia was not our focus in the present study due to the low power of the 
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small animal number, though the trend generally followed that of the quantitative markers 
(higher in the H1 and H2 groups and lowest in N0).  
 
Thus, the data we present here corroborates previous studies of N10 amplitude and 
qSSEP-PSA under normothermic conditions and it is necessary to extend the present study 
with larger animal numbers, including a sham group. The quantitative SSEP markers 











CHAPTER 5: ASSOCIATION OF CEREBRAL BLOOD 
FLOW AND QUANTIFIED EEG AFTER CARDIAC 
ARREST  
5.1   Introduction  
Cardiac arrest (CA) frequently causes cerebral ischemic injury by reducing or completely 
halting blood flow to the brain. This lack of cerebral perfusion is critical in the poor 
outcomes that result from CA. In addition to the damage done by the anoxic ischemic 
state, it has been suggested that reperfusion injury occurs following resuscitation [180] by 
free radicals [181, 182] or diapedesis of red blood cells [183]. Additionally, it has been 
suggested that autoregulation of CBF is absent or right-shifted in the early recovery 
period following CA [184]. Thus, it is important to understand the dynamics of CBF 
following CA.  
 
Cortical electrical activity has been widely studied in anoxic ischemic injury cases and 
specifically in regards to CA applications. Continuous electroencephalogram (EEG) has 
become an extremely common tool to measure cortical electrical activity in comatose 
patients [185, 186], including those recovering from CA. Certain EEG characteristics 
have been associated with unfavorable outcomes such as burst suppression, low voltage 
activity and epileptiform pattern [42]. Many studies have classified EEG wave patterns 
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into groups corresponding to different levels of activity for prognostic purposes or to 
elucidate the EEG pattern recovery following CA in human studies [29, 42, 97, 99, 104-
107, 132, 147, 187-193]. Thus, the cortical electrical activity holds significant prognostic 
value in the recovery following CA.  
 
Our group previously developed novel methods to quantify EEG signals and measure 
rCBF with high spatial and temporal precision. In order to reduce the laborious and 
subjective interpretation of EEG signals, here we use a quantitative measure of the 
entropy within EEG signals, information quantity (IQ) [110]. Previous studies have 
shown that the IQ metric successfully tracks brain recovery and predicts functional 
outcome after CA in rats [46, 110]. To measure rCBF in CA rats, our group developed a 
laser speckle contrast imaging (LSCI) system to continuously track the rCBF changes 
during and after CA with high temporal and spatial resolution. LSCI is an emerging 
imaging tool primarily used for blood flow imaging, which quantifies the resulting 
pattern of coherent light interference, termed the speckle pattern, due to blood flow [194].  
 
Both rCBF and cortical electrical activity play an important role in recovery in the early 
stages following CA. Hypothermia is known to decrease rCBF in uninjured brains [195, 
196], however, it is not well understood how rCBF correlates with the electrical activity 
under hypothermic conditions following CA. In this study, LSCI and IQ analyses were 
applied to CA rats to characterize the relationship between the average rCBF of the 
98 
arteries, veins and capillaries of the primary motor cortex and cortical electrical activity 
during the early recovery after CA with targeted temperature management (TTM).  
 
5.2   Materials and Methods  
5.2.1   Animals  
A total of 28 adult Wistar rats (322±8g) were used for these experiments. Each animal 
was randomly assigned to one of four groups (n=7 per group): 7min CA or 9min CA 
under normothermia (36.5°C-37.5°C, group name 7N or 9N, respectively), or 7min or 
9min CA under hypothermia (32°C-34°C, 7H or 9H, respectively). All animals 
underwent asphyxia-CA and immediate temperature management following resuscitation 
according to their assigned group. The rats were housed in a controlled temperature 
environment with a standard dark/light cycle with food and water ad libitum. All 
experimental protocols were approved by the University of Maryland Institutional 
Animal Care and Use Committee.  
  
5.2.2   Experiment Preparation  
All rats underwent an implantation procedure under sterile conditions one day prior to 
CA. A heating pad was used to control animals’ rectal temperature (36.5-37.5°C) 
throughout the procedure. The animals were placed in a stereotactic frame (David Kopf 
instruments, Tujunga, CA) with continuous 1.5% isofluorane anesthetization. An incision 
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was made in the skin over the scalp and a left hemisphere cranial window was prepared 
(7mm x 5mm, centered at AP -1, ML -2.5) [197]. A cylinder base (height: 4.2mm, radius: 
5.5mm, thickness: 0.5mm) was fixed by dental cement encircling the cranial window and 
connected to the imaging system during acquisition. Three screw electrodes (Plastics One, 
Roanoke, VA) were cortically implanted in the right hemisphere to record the EEG [114].  
 
5.2.3   Cardiac Arrest, Resuscitation and Temperature Management  
CA and immediate temperature control during the early recovery period with EEG 
monitoring were performed as previously described in detail [46, 110, 113, 145]. Briefly, 
the rats were intubated, mechanically ventilated, and anesthetized with 1.5% isofluroane 
in 1:1 O2:N2. Arterial blood gases (ABG) and blood pressure were monitored, and drugs 
were delivered via the cannulated femoral artery and vein, respectively. A 5 min baseline 
EEG measurement was recorded, followed by a 5 minute anesthesia washout period, 
during the final three minutes of which the ventilation was switched to room air and 
vecuronium (2mg/kg) was administered. Asphyxial CA was induced until pulse pressure 
< 10 mmHg. After 7 or 9 mins of asphyxia depending on the rats’ group, mechanical 
ventilation was resumed and cardiopulmonary resuscitation (CPR) was performed using 
sternal chest compressions and epinephrine until the return of spontaneous circulation 
(ROSC) was achieved. Sodium bicarbonate was administered with the epinephrine during 
CPR to prevent acidosis.    
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The rats’ rectal temperature was monitored using a rectal probe and recorded every 5 min. 
Normothermia animals were maintained at 36.5-37.5°C using a heating pad for 8 hrs after 
ROSC. Hypothermia animals were cooled beginning immediately after ROSC using a 
misted water and alcohol solution and fan to reach a target temperature of 33°C ± 1°C 
within 15 min. Hypothermia was maintained for 6 hours, after which the rats were 
rewarmed to normothermia (36.5-37.5°C) using a heating pad and thermal heating lamp 
(Thermalet TH-5, model 6333, Physiotemp, NJ, USA) over a period of 2 hours. To 
maintain normothermic body temperature, all animals were kept in a neonatal incubator at 
28°C for the first 24 hours after ROSC.  
 
5.2.4   Laser Speckle Contrast Imaging  
The CBF was recorded for each rat using the LSCI system. An 8-bit COMS camera 
(DCC1240C, Thorlabs) was connected to the cylinder base previously implanted and was 
used to capture the images. A laser diode (780nm; 10mW; L780P010, Thorlabs), 
powered by a driver module (LDC220C, Thorlabs) was the coherent light source 
illuminating the region of interest (ROI). Each trial acquired 320 consecutive frames of 
speckle pattern images (640x640 pixels) at 50 frames/sec and 5ms exposure time. LSCI 
data were obtained beginning at the 5min anesthetic washout and ending at 90min after 
ROSC. LSCI analysis was performed to calculate rCBF. The individual cortical artery 
and vein rCBFs were calculated in the ROI and normalized to the washout period 
baseline. By selecting a 1mm x 1mm ROI centered at the primary motor cortex (M1, AP -
1.5; ML -0.5), the capillary rCBF was obtained by eliminating cortical arteries and veins 
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from the images [197]. The overall rCBF used in the results of this chapter was calculated 
by averaging the vein, artery and capillary rCBFs.  
 
5.2.5   EEG Acquisition and Analysis  
Following the baseline measurement prior to washout, continuous EEG was recorded 
during the anesthetic washout, CA and for 6 hours post-ROSC. Noise was removed in the 
frequency domain using custom MATLAB algorithms (Mathworks, Natick, MA) and 
artificial signals were manually eliminated prior to the final analysis. The EEG signals 
were then quantified using an entropy-based value, IQ [110]. Briefly, the EEG signals 
were divided into equal lengths using a sliding temporal window technique (window 
length ω=8s, sliding step Δ=8s, number of magnitude levels M=20). Then a discrete 
wavelet transform (decomposition scale r=5) was applied to each temporal window to 
generate decomposition coefficients, c , where k=1,2…r+1,m which represents the kth 
frequency subband. Since the Shannon entropy is probability-based, the distribution of 
wavelet coefficients was determined in each time window by finding the probability, 
p m , of each coefficient. We used M bins, I , to determine the occurrence frequency 
of each coefficient in each bin (Eq. 1).  
    	 c , c , … , c ⋃ I            (1) 
Finally, the IQ of the EEG samples was calculated using the entropy formula (Eq. 2).  
   	IQ n 	 ∑ p m ∙ log p m            (2) 
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The IQ was calculated at 10, 20, 30, 60, and 90 min post-ROSC and normalized to the 
baseline value.  
 
5.2.6   Neurological Evaluation   
The neurological function of each animal was assessed at 6, 24, 28 and 72 hrs after CA 
using the neurological deficit scale (NDS). The 72hr NDS was used to define functional 
outcome as either good (72hr NDS ≥ 60) or poor (72hr NDS < 60) [46].   
 
5.2.7   Statistics  
All statistical analyses were performed using a commercial statistical computer package 
(IBM SPSS Statistics, version 22, Armonk, NY). Baseline data, IQ, and rCBF were 
compared between groups using an analysis of variance with repeated measures 
(ANOVA). The NDS was compared between the four animal groups using a Kruskall-
Wallis test and between temperature and CA groups using a Mann-Whitney U test. The 
correlation between rCBF and IQ was determined using the Pearson correlation 
coefficient test. A p value < 0.05 was considered significant.  
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5.3   Results 
5.3.1   Baseline Data and Temperature Maintenance  
The baseline animal body weight, rectal temperature and anesthetic exposure during 
preparation were not significantly different among groups (Table 5.1). The temperature 
was well monitored throughout the duration of the experiment for all animals. The 
normothermic groups were maintained at 36.81±0.02°C for 7minCA and 36.85±0.02°C 
for 9min CA while hypothermic groups were maintained at 33.85±0.03°C for 7min CA 









Figure 5.1 Body temperature of each animal group was maintained at their respective value throughout the temperature management 
period.   
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Table 5.1 Baseline data for each animal group 
 7N 7H 9N 9H P value 
Body weight 
(g) 












5.3.2   NDS Scores   
The 72 hour NDS was not significantly different between the four animal groups or 
between temperature or CA time groups (p>0.05). However, the combination of NDS 
scores at all time point for each animal were significantly different between temperature 
groups (p<0.01) and CA time groups (p<0.01) such that hypothermia animals had higher 
median NDS (66 (49, 74)) compared to normothermia animals (47 (35, 70)) and 7min CA 
animals had higher median NDS (70 (47, 77)) compared to 9min CA animals (47 (35, 
66)).  
 
5.3.3   Changes in Relative Cerebral Blood Flow 
The normalized rCBF was greatly decreased during the final 4 min of CA, and then 
increased back to or above baseline levels at 10 min after ROSC, representing the 
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hyperemia phase (Fig. 5.2). The rCBF then decreased below baseline from 20-90 min 
after ROSC, representing the prolonged hypoperfusion phase. This trend was generally 
observed in all four animal groups (Fig. 5.2). The rCBF values for each group within 
each time period are shown in Table 5.3.  
 
 
Fig 5.2. Time evolution of the normalized rCBF of all vessels throughout the experiment. 
The rCBF decreased greatly during the final 4 min of CA, then increased back to or 




5.3.4   Changes in Quantitative EEG 
The IQ of each of the four animals groups increased over the early recovery period from 
10-90min after ROSC (Fig 5.3). The 7H animals showed better recovery of IQ by 90min 
post-ROSC while the 9N showed the worst recovery (Fig 5.3). The IQ values for each 
group within each time period are shown in Table 5.3.  
 
 
Fig 5.3. Time evolution of the EEG information quantity (IQ) throughout the experiment. 
The IQ generally increased over time for each animal group, with the 7H group showing 
the best recovery.   
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5.3.5   Correlation Between rCBF and IQ 
As shown in Figure 5.4, the rCBF and IQ of all four animal groups had a significant 
negative correlation during the first 90min after ROSC (Pearson correlation coefficient: -
0.680, p<0.01). The negative correlation was also significant at 20min (Pearson 
correlation coefficient: -.550, p<0.01) and 90min (Pearson correlation coefficient: -0.473, 





Fig 5.4. rCBF and IQ of all animal groups during the first 90min after ROSC are 






Table 5.2 Pearson correlation coefficients for rCBF and IQ   
















* p < 0.05, ** p < 0.01 
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Table 5.3. rCBF and IQ (mean±S.E.M.) Early Recovery Period Data  
Group Variable Aggregate 10min 20min 30min 60min 90min 
7N IQ 0.522±0.038 0.220±0.074 0.407±0.064 0.563±0.031 0.678±0.027 0.740±0.031 
rCBF 0.858±0.026 1.054±0.057 0.874±0.038 0.736±0.034 0.808±0.033 0.833±0.046 
7H IQ 0.590±0.067 0.137±0.032 0.249±0.041 0.719±0.082 0.906±0.059 0.941±0.070 
rCBF 0.858±0.029 1.001±0.026 1.050±0.031 0.821±0.053 0.719±0.043 0.745±0.041 
9N IQ 0.366±0.034 0.170±0.039 0.175±0.040 0.421±0.044 0.508±0.041 0.575±0.041 
rCBF 0.929±0.021 1.065±0.033 1.013±0.017 0.783±0.016 0.862±0.026 0.923±0.040 
9H IQ 0.415±0.049 0.147±0.020 0.136±0.019 0.420±0.051 0.667±0.041 0.741±0.049 
rCBF 0.866±0.024 0.976±0.021 1.030±0.018 0.812±0.038 0.729±0.039 0.783±0.035 
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5.4   Discussion  
We have importantly demonstrated, for the first time, that the rCBF is negatively 
correlated with IQ during the early recovery period (first 90min post-ROSC) following 
CA, and more specifically, at 20min and 90min post-ROSC. The IQ metric is 
representative of the cortical electrical activity. The EEG electrical activity, visibly 
shown as a bursting pattern, is indicative of the recovery of various cortical and 
subcortical regions following CA [103, 198] and is predictive of final outcome [104-107]. 
The cortical CBF and cerebral metabolic rate of oxygen (CMRO2) both decrease in the 
early period following CA due to increases in cerebral vascular resistance [199, 200], 
thereby impacting the neurological recovery [201]. Additionally, it has been shown that 
there is a linear relationship between electrical activity and CMRO2 [202]. Under 
standard physiological conditions, increases in electrical activity result in adjusted 
increases in CBF, generally within seconds [203-208]. However, as shown in the present 
study, under pathological conditions following CA, electrical activity, represented by IQ, 
tends to increase over the recovery period while rCBF tends to decrease, after a brief 
hyperemia phase, indicating an uncoupling of the EEG and rCBF relation, which is 
supported by previous studies [209]. Therefore, the negative correlation between IQ and 
rCBF suggests that a lower rCBF can still support increasing electrical during the 
recovery period. The correlation also importantly indicates that rCBF may hold 
prognostic value for post-CA patients.  
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Further, the relationship between rCBF and electrical activity may help uncover the 
mechanisms of the influence that rCBF has on post-CA recovery. One study found that 
patients who regained consciousness following resuscitation all had normal CBF values 
while those who died before regaining consciousness had increased CBF within 24 hours 
after resuscitation [210]. This generally supports the observation in the present study that 
the positive relation between electrical activity and rCBF is disrupted by CA, resulting in 
a negative correlation. Further, one study determined the relationship between electrical 
activity, as measured by somatosensory evoked potential (SSEP) amplitude, and CBF 
during and after acute middle cerebral artery occlusion, and identified two relationships: 
time-dependent and steady state [201]. Ultimately, due to the steepness of the steady state 
relationship, the authors explain that a small increase in CBF may result in the electrical 
recovery that is seen after the occlusion, which may be similar to the observations in the 
present study.  
 
5.5   Conclusion  
This study demonstrated that the increasing relation between electrical activity, measured 
here by IQ, and rCBF under physiological conditions is disrupted following CA, resulting 
in a negatively correlated relation. Specifically, we verified that a rCBF lower than 
baseline is able to support electrical recovery and subsequent functional recovery in the 
early post-CA period. Additionally, this relation suggests that rCBF, as obtained by our 
novel LSCI system, may hold potential prognostic value in CA applications, though this 
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was not directly addressed in the present study. Ultimately, the relationship between IQ 



















CHAPTER 6: SUMMARY AND FUTURE DIRECTIONS  
6.1   Summary  
The work in this thesis was primarily focused on the evaluation of novel quantitative 
markers in the prognostication of post-CA subjects, using a rodent model. We determined 
that SSEP signals hold prognostic value in the form of continuous, quantitative markers, 
and may provide more benefits than the current binary present/absent standard. 
Specifically, we found that N10 amplitude and N7 and N10 latencies of rat SSEPs under 
TTM following CA have different evolution patterns over the early recovery period, 
dependent on final functional outcome with both moderate and severe injury. Further, we 
demonstrated that the qSSEP-PSA marker is distinct among temperature and outcome 
groups in the early recovery following CA. We examined the relation between rCBF and 
EEG electrical activity, and found a negative correlation during the early recovery period. 
Ultimately, we have demonstrated that a multimodal approach using numerous 
quantitative measures such as SSEP peak amplitudes and latencies, qSSEP-PSA, IQ and 
rCBF, may optimize prognostication during the early recovery period following CA.   
To summarize, in this work we:  
 Reviewed the benefits and limitations of existing prognostic tools that are used in 
post-CA patients in a clinical setting. 
 Acknowledged the benefits of SSEP in prognostication and reviewed the benefits 
and limitations of the standard SSEP analysis, which involves the dichotomous 
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classification of N20 peaks as either present or absent, where bilaterally absent 
N20 peaks predict poor outcome with 100% specificity.  
 Evaluated the prognostic value of N10 amplitude and N7 and N10 latency of post-
CA rat SSEPs during the first 4 hours of recovery under targeted temperature 
management. We found that the N10 amplitude has a better recovery in 
hypothermia animals compared to other temperature groups and predicts good 
outcome following CA.  
 Assessed the evolution of the qSSEP-PSA marker in post-CA rats with 
temperature management. We discovered that the qSSEP-PSA marker evolves 
differently depending on temperature and outcome groups, such that hypothermic 
animals and animals with good functional had upward trending qSSEP-PSA 
values towards the end of the early recovery period, while the other groups tended 
to trend down or stabilize at lower values.  
 Performed a multimodal analysis of SSEPs following severe brain injury by CA 
under graded hypothermia in a pilot study. We discovered that N10 amplitude and 
latency and qSSEP-PSA all demonstrated distinct trends among both temperature 
and functional groups during the early recovery period under graded hypothermia. 
We also demonstrated that N10 amplitude is correlated with both N10 latency and 
qSSEP-PSA during the recovery period. Importantly, we established that these 
markers hold the potential to track recovery following severe cerebral injury. 
 Examined the relation between cerebral electrical activity, measured by IQ, and 
rCBF during CA and throughout the subsequent early recovery period. We 
discovered that the increasing relation that exists between IQ and rCBF under 
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physiological conditions is disrupted following CA, and ultimately results in a 
negative correlation between markers. We showed that lower than baseline rCBFs 
can support electrical recovery following CA.  
 
6.2   Future Directions  
The work presented in this thesis provided the foundation for future work to further 
develop quantitative markers to improve prognostication during the early recovery period 
from CA. Possible future work includes:  
 Larger animal studies with severe cerebral injury (by 9min asphyxia-CA) to better 
evaluate the performance of N10 amplitude, N7 and N10 latency, and qSSEP-
PSA in tracking recovery under temperature management.  
 Validation and optimization of cut-off points of the quantitative markers 
presented, to predict functional outcome.  
 Development of a multimodal approach including short-latency SSEP amplitude 
and latencies, qSSEP-PSA, IQ and rCBF. 
 Further examination of rCBF using LSCI, in terms of distinct vessel rCBF and the 
respective relations with electrical activity during CA and the early recovery 
period following resuscitation. This work may contribute to uncovering the 
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